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In this dissertation, efforts were dedicated to develop analytical methods to 
resolve the quality- related problems (lack of consistency, safety and efficacy) 
of herbal medicines. This dissertation is divided into 2 parts: Part I (Chapter 2 
& 3) focused on the extraction and determination of the toxic compounds and 
quality assessment of herbal medicines (comfrey and chrysanthemum 
respectively) using Pressurized Hot Water Extraction (PHWE) and High 
Performance Liquid Chromatography (HPLC); and Part II (Chapter 4 & 5) 
focused on the metabolic and metallomic effects of berberine using Gas 
Chromatography Mass Spectrometry (GC-MS), Nuclear Magnetic Resonance 
(NMR) and Inductively Coupled Plasma Mass Spectrometry (ICP-MS). 
In Chapter 1, the herbal medicine analysis was briefly reviewed and 
introduced from various aspects, including the extraction, the separation and 
detection as well as metabolomics and metallomics. 
Symphytum officinale L. (comfrey) is a medicinal plant commonly used in 
decoctions and aliments; however, the hepatotoxic Pyrrolizidine Alkaloids 
(PAs) are found to be present in it. In Chapter 2, qualitative detection of PAs 
such as lycopsamine, symviridine and their N-oxides could be confirmed with 
a newly elaborated HPLC ion-trap and orbitrap MS with electrospray 
ionization interface; and using PHWE and heating under reflux, quantitative 






Chrysanthemum is a famous herbal medicine with many species and wide uses; 
and in chapter 3, an economical and effective quality assessment approach 
using green-solvent methods based on PHWE for the extraction of different 
chrysanthemum and combined with simple and high throughout HPLC-UV for 
detection was developed. Chromatographic fingerprints obtained from the 
HPLC-UV analysis of the PHWE extracts together with the aid of Principal 
Component Analysis (PCA), allowed for the classification and separation of 
various chrysanthemums of different species, provenance, etc.  
Berberine possesses many properties including the cholesterol- lowering 
property. In chapter 4, to study the berberine effect, a combination of GC-MS 
and 1H NMR is used to provide a comprehensive picture of the metabolic 
profiles of the liver, serum, heart and kidney samples associated with the 
weight loss and cholesterol lowering effects of berberine in the liver of 
hypercholesterolemic rats. Berberine modified the hepatic cholesterol 
biosynthesis and a shift in the metabolism of fatty acids in the liver, heart and 
kidney was observed.   
In order to study the berberine effect more deeply, a combined metabolomic 
and metallomic approach was developed in Chapter 5, which involved the use 
of 1H NMR for the analysis of rat urine to achieve metabolic fingerprinting, 
and the use of ICP-MS for the analysis of rat blood serum to achieve metallic 
fingerprinting. The results obtained indicated that major metabolic processes 
like Krebs cycle, amino acid metabolism, cholesterol metabolism and 





unprecedented multi-analytical approach provides an information-rich 
platform for drug efficacy studies. 
In summary of this study, the analytical tools including PHWE, LC-MS, GC-
MS, ICP-MS ans NMR have been proven to be powerful for the investigation 
of herbal medicines in many aspects.  
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Chapter 1 Introduction 
1.1 Overview of herbal medicine analysis 
Herbal plants are well-recognized for their ability to synthesize medicinal 
compounds. The use of herbal plants has a long history throughout the world. 
In recent years there has been a growing interest in natural or herbal remedies 
worldwide, partly because of the realization that modern medicine is not 
capable of providing a ―cure-all‖ solution against human diseases and that the 
presence of unwanted side-effects is almost unavoidable. Unlike modern drugs 
that invariably comprise a single active ingredient, herbal extracts and/or 
prescriptions contain multiple active constituents. Interestingly, natural 
compounds contained in these ―herbal cocktails‖ can act in a synergistic 
manner within the human body, and can provide unique therapeutic properties 
with minimal or no undesirable side-effects. A key factor in the widespread 
acceptance of natural or alternative therapies by the international community 
involves the ―modernization‖ of herbal medicine. In other words, the 
standardization and quality control of herbal materials by use of modern 
science and technology are critical (1). At present, however, quality- related 
problems (lack of consistency, safety, and efficacy) seem to be overshadowing 
the potential genuine health benefits of various herbal products, and a major 
cause of these problems seems to be related to the lack of simple and reliable 
analytical techniques and methodologies for the chemical analysis of herbal 
materials. 




Sample preparation is the crucial first step in the analysis of herbs, because it 
is necessary to extract the desired chemical components from the herbal 
materials for further separation and characterization. Thus, the development of 
modern sample preparation techniques with significant advantages over 
conventional methods for the extraction and analysis of medicinal plants is 
likely to play an important role in the overall effort of ensuring and providing 
high-quality herbal products to consumers worldwide. Specificially, new 
sample preparation techniques will need to possess advantages such as 
reduction in organic solvent consumption, elimination of additional sample 
clean-up and concentration steps, improvement in extraction efficiency and 
ease of automation. 
Nowadays, there are many separation and detection techniques of herbal 
medicines available, thus making the choice and development of an 
appropriate method are important. The major goal for the determination of 
toxic compounds is accuracy and sensitivity, and thus an accurate and 
sensitive method is needed. Due to the large number of samples involved in 
the chemical profiling for quality control analysis, methods that are simple and 
yet with high throughput capabilities are favoured. 
Advances in analytical instrumentation in the last couple of decades have 
allowed the global analysis of biological compounds such as DNA (genomics), 
RNA (transcriptomics), proteins (proteomics) and small molecules 
(metabolomics). Metabolomics is the evaluation of biological systems for 
changes in endogenous metabolite levels that result from disease or 
therapeutic treatments. One of the strategies employed by metabolomics is 




metabolic fingerprinting, which involves rapid, high- throughput global 
analysis to distinguish between samples of different biological status or origin 
by pattern recognition. Furthermore, it is increasingly recognized that 
assessment of limited biomarker compounds to monitor therapy efficacy is 
fundamentally flawed and that more comprehensive snapshots of multiple 
metabolites must be taken. Such an approach is commonly employed in 
metabolomics investigations of the efficacy of herbal medicines.  
Metallomics is the study of metals and metal species, and their interactions, 
transformations and functions in biological systems.  It is an emerging research 
area and is proposed as the interdisciplinary field for the promotion of 
biometal science. Metal ions play biologically important roles in maintaining 
the physiological functions in life systems, keeping organism healthy under 
the homeostasis conditions. There can be little doubt that the addition of 
metallomics to metabolomics will greatly enhance the understanding of 
mechanisms of drug effect, and of the biology underlying individual variation 
in drug response phenotypes. 
1.2 Extraction techniques 
1.2.1 Traditional extraction technique  
Sample preparation is the first crucial step in the analysis of herbal medicines 
for further separation and characterization. Getting the sample preparation 
stage correct can be economically valuable as well as analytically important in 
the past few decades. Even though separation methods may provide high 
resolution of complicated mixtures, the whole analytical process may still be 




nullified if an unsuitable sample preparation method has been utilized before 
chromatographic analysis, i.e. poor sample treatment will invalidate the whole 
assay, despite the use of the most powerful techniques. Therefore, an 
inefficient or incomplete sample treatment can represent a considerable 
constraint on the throughput of any analytical method (2). 
For herbal medicines, the target class components may range from non-polar 
to polar and thermally labile to stable, so that the suitability of the extraction 
method must be considered carefully. In addition, the presence of analyte-
matrix interaction in herbal materials may hinder the extraction process. 
Different methods of extraction with different conditions may often be 
required for the extraction of interested candidates from different herbal plants. 
Even with the same techniques of extraction, for different analytes of interest 
in the same plants, different experimental conditions such as the solvent used, 
temperature applied and others should be considered. 
The basic extraction procedure consists of several steps including pre-washing, 
drying, grinding to obtain a homogenous sample and in most cases, improving 
the kinetics of analyte extraction. For the monographies stated in the United 
States, Japanese and Chinese pharmacopeia, methods, such as sonication, 
heating under reflux, soxhlet extraction, steam distillation and others are 
commonly used. These methods have been considered as ―class ic‖, and they 
can be used to investigate the extraction efficiencies of the novel extraction 
methods after comparison. However, these methods would be time-consuming 
and require the use of large amount of organic solvent and have lower 
extraction efficiencies when the analytes of interest are not easily extractable.  




1.2.2 Modern extraction technique 
In the move to reduce or eliminate the use of organic solvent and improve the 
extraction processes, newer sample preparation methods, such as microwave 
assisted extraction (MAE), supercritical fluid extraction (SFE) and accelerated  
solvent extraction (ASE) or pressurized liquid extraction (PLE) have been 
introduced for the extraction of analytes present in plant materials. All 
developed methods have been geared toward to the following trends (2): 
(1) High speed during the extraction process,  
(2) Smaller initial sample sizes even for trace analysis,  
(3) Greater specificity or greater selectivity in extraction,  
(4) Potential for automation or on- line methods with manual 
operations, 
(5) More environmental friendly approach with less waste and the 
use of small volumes or no organic solvents. 
The principles of all new extraction techniques are briefly discussed as follows. 
For MAE, not only is the microwave energy used for solution heating to result 
in significant reduction of extraction time, it also enables a significant 
reduction in the consumption of organic solvents. For SFE, with the unique 
properties of supercritical fluid such as higher diffusion coefficient and lower 
viscosity, it allows more efficient extraction with high selectivity, even in 
complicated mixtures. For PLE, the extraction medium posesses the 
advantageous mass transfer properties under high pressure and temperature 




environment; furthermore, low viscosity properties of extracting solvent 
disrupt the solute-matrix interactions and increase the diffusion coefficients, so 
that extraction efficiency becomes higher (3, 4). Pressurized Hot Water 
Extraction (PHWE) is a version of PLE, in which the solvent is mainly water. 
PHWE has become a popular green extraction method for different classes of 
compounds present in numerous kinds of matrices such as environmental (5), 
food and botanical samples, as it is a quick, efficient and environmentally 
friendly technique for extractions (6). 
1.2.2.1 Theory of Pressurized Hot Water Extraction (PHWE) 
The fundamental principle of PHWE is the changes in physicochemical 
properties of water. Water is a highly polar solvent with a high dielectric 
constant (ε) at room temperature and atmospheric pressure due to the presence 
of extensive hydrogen-bonded structure. Hence, traditionally water is not 
considered as a suitable extraction fluid for non-polar or organic compounds at 
room temperature. When the temperature of water is raised, there is a steady 
decrease in its permittivity, viscosity and surface tension but an increase in its 
diffusivity. With enough pressure to maintain water in the liquid phase at 
elevated temperature, the initial value of the dielectric constant of 80 at 25 °C 
and 10.1325 bar decreases to 27 at 250 °C and 50 bar, which falls between the 
dielectric constants of methanol (ε=33) and ethanol (ε=24) at 25 °C and 
10.1325 bar. Under these conditions, water behaves like certain organic 
solvents which can dissolve analytes with a wide range of polarities (5, 7). 




Parameters that significantly affect the selectivity and extraction efficiency of 
PHWE are temperature, pressure, extraction time, flow rates and 
modifiers/additives. Different parameters can be optimized in order to obtain 
the highest recoveries. Among them, the most important are the temperature 
and the pressure; other parameters have shown little influence on the final 
recoveries and they are usually fixed.  
Temperature is the main factor which could affect the extraction efficiency 
and selectivity in PHWE. It could influence the physicochemical properties of 
water and also subject thermally labile analytes to decomposition or hydrolytic 
attack. The physical advantages such as high diffusion, low viscosity and low 
surface tension are achieved at elevated temperature condition. The increased 
vapour pressures and rapid thermal desorption of target compounds from 
matrices could enhance the extraction efficiency of PHWE (8). The high 
temperatures can also change the properties of water, thus making the polarity 
of water closer to those of non-polar compounds. This will enhance the 
solubility of less polar compounds in water for improved extraction from 
different matrices (9-11). However, degradation of compounds and the 
intensity of reactions such as hydrolysis and oxidation can occur with 
increased temperature. Thus, a systematic optimization on temperature has to 
be carried out for the respective classes of compounds (5). 
The effect of adjusting pressure could change the phases o f water. Moderate 
pressures such as 15 bar at 200 °C and 85 bar at 300 °C are required to 
maintain the liquid phase of water (5). Pressure is usually varied from 10 to 80 
bars to maintain water in its liquid phase at extraction temperature, but applied 




pressure has been found to have little effect on the extraction efficiency of 
PHWE. 
The other parameters that would influence the efficiency of PHWE include the 
flow rate and the extraction time, as well as the use of modifiers and the 
additives. As PHWE is usually carried out in the dynamic mode, both 
extraction time and flow rate are important parameters for the optimization. 
The extraction time depends on the extraction temperature, nature of matrix 
and analytes. Using PHWE, it was observed that an extraction time of 20 min 
could give higher yields of targeted compounds in botanicals. As for the flow 
rate, 1 or 1.5 mL/min is usually used (5). 
1.2.2.2 Instrumentation of PHWE 
Instrumentation is pivotal to PHWE, and the experiments were generally 
performed using a laboratory set-up (12, 13). Figure 1.1 shows the typical set-
up of PHWE (14). The backpressure is generated using a back pressure 
regulator by VICI Jour Research (Onsala, Sweden). This set-up consists of a 
stainless steel preheating coil to ensure that the water is at the operating 
temperature prior to entering the extraction cell. The stainless steel tubings 
used are 1/16 in. O.D. and 0.18 mm I.D. The set-up consists of stainless steel 
extraction cells with 10 mm I.D. × 150 mm with volumes of 10 mL or larger. 
The extraction cell is heated in a gas chromatograph oven and a pump is used 
to pump the fluid into the extraction cell. By pressurizing the sample cell, it is 
possible to keep the fluid in liquid phase at the high extraction temperatures 
used of up to 200 °C. From the systems that have been built, care must be 




taken to avoid the blockage of narrow bore tubing by precipitate when the 
botanical extracts leave the oven. This set-up has the advantage of automation, 
and the final herbal extracts could be obtained directly in the collection tube 
without filtration or other post-treatment steps. Hence, this kind of set-up 









Figure 1. 1 Schematic diagram of an alternative laboratory made PHWE 
system proposed by Ong etc. (14) 
 
1.2.2.3 Application of PHWE 
Since the polarity of water decreases markedly when liquid water is under 
elevated temperature ranging from 100 to 374 °C and elevated pressure, water 
can be used for the pressurized hot water extraction (PHWE) of a wide range 
of analytes: 




(1) Extraction of contaminants, pharmaceuticals and personal-care 
products from environmental samples; 
(2) Extraction of nutritional compounds and removal of organic 
contaninants in foodstuff;  
(3) Extraction of bioactive and nutritional compounds from botanicals and 
medicinal plant materials.  
PHWE has been widely used in herbal plants studies. Fernandez-Perez et al. 
reported the application of PHWE to the extraction of essential oils in plant 
materials (15). Zhang et al. reported the use of PHWE for 3 kinds of analysis: 
1) α-asarone in the dry rhizome of the common Traditional Chinese Medicine 
(TCM) Acorus Tatarinowii Schott (16), 2) Z-ligustilide and E- ligustilide, from 
Ligusticum chuanxiong and A. sinensis (17), and 3) volatile active compounds 
such as Fructus amomi (18). Ong et al. investigated the application of PHWE 
for extraction of berberine in coptidis rhizoma, glycyrrhizin in radix 
glycyrrhizae/liquorice and baicalein in scutellariae radix, and compared PLE 
(with methnol as solvent) with PHWE (14). However, the applications of 
PHWE in the determination of toxic compounds and the quality control of 
herbal medicines are still limited. 
1.3 Chromatographic techniques as the separation and detection tools in 
herbal medicine analysis  
Most of the naturally occurring compounds in herbal medicines could be 
separated by conventional methods like Thin Layer Chromatography (TLC), 




which have now largely been replaced by Gas Chromatography (GC) and 
High Performance Liquid Chromatography (HPLC). Both of them are 
nowadays the most useful and popular techniques for the analysis of natural 
products and other compounds in complex botanical matrices (19). 
1.3.1 Gas Chromatography (GC) 
Many bioactive components in herbal medicines are volatile chemical 
compounds, so gas chromatography (GC) is appropriate for the analysis of 
volatile composition in herbal medicines. The advantages of GC clearly lie in 
its high sensitivity of detection for almost all the volatile chemical compounds. 
In addition, the high selectivity of capillary columns enables separation of 
many volatile compounds simultaneously within comparatively short times. 
This is especially true for the usual Flame Ionization Detector (FID) and Mass 
Spectrometry (MS) detection. Futhermore, interfaced with MS detector and 
utilizing the mass spectral database, reliable qualitative and relatively 
quantitative analysis of the chemical composition of herbal medicines could be 
provided. This could be extremely valuable for further study in elucidating the 
relationship between chemical constituents in herbal medicines and its 
pharmacology. However, the most prominent disadvantage of GC is that it is 
not convenient for its analysis of the samples of polar and non-volatile 
compounds. For this, it is necessary to use tedious sample work-up which may 
include derivatization. Therefore, the liquid chromatography becomes another 
necessary tool for us to apply the comprehensive analysis of the herbal 
medicines (20). 




1.3.2 High Performance Liquid Chromatography (HPLC) 
High performance liquid chromatography (HPLC) with an isocratic/gradient 
elution remains the method of choice in the pharmacopeia (21). It is a very 
popular analytical method for herbal medicines because the method is no t 
limited by the volatility or stability of the analytes. The comparative advantage 
of HPLC lies in its versatility for the analysis of the chemical compounds in 
herbal medicines. Therefore, almost all compounds in herbal medicines can be 
analyzed through HPLC. 
1.3.2.1 Liquid chromatography with ultraviolet absorbance detection 
(LC-UV) 
The most common mode of detection for liquid chromatography remains to be 
ultraviolet detection. LC-UV has the best combination of sensitivity, linearity, 
versatility, and reliability of all the LC detectors developed so far. Also, it is 
an analytically useful technique with advantages of high reproducibility, ease 
of automation and ability to analyze a lage number of constituents in 
botanicals and herbal preparation (21). 
Three types of UV detectors are available: fixed-wavelength, multiple-
wavelength, or Diode Array Detection (DAD). The fixed-wavelength detector 
is the least expensive and has higher intrinsic sensitivity because the light is 
emitted at specific wavelengths with given lamps. However, the multiple-
wavelength detector is more versatile and can often compensate for its lower 
sensitivity when a wavelength with the highest extinction coefficient for the 
solute of interest is chosen. The DAD will be treated in the hyphenation 




section, as it can provide complete UV spectra of the constituent during 
separation. Limits of detection (LODs) can reach 10-8 g/mL, with a linear 
dynamic range of about three orders of magnitude (22). 
Many publications refer to the application of HPLC-UV for the detection of 
natural products having a chromophore for both quantification and profiling 
purposes (22). Methods using gradient elution HPLC with reversed phase 
columns were applied for the analysis of mult iple constituents present in 
medicinal plants and herbal preparations (23). Gradient elution HPLC with 
ultraviolet detection, using a C18 reversed phase column was used to profile 
components present in a number of herbal medicines (21). HPLC-UV also has 
been used for the quantification of flavonoid, naphthodianthrone, and 
phloroglucinol constituents of Hypericum perforatum. The developed method 
used a ternary solvent system in the gradient mode (50 min) and enabled a 
baseline separation of 16 main constituents, which were quantified based on 
their relative response factors at 270 nm and compared with rutin as an 
external standard (24). A more rapid method (5 min) using fast-gradient 
elution for a specific determination of naphthodianthrones (590 nm) a nd 
phloroglucinols (270 nm) has also been reported (25). Many papers refer to 
the HPLC-UV analysis of another important herbal drug, Ginkgo biloba. A 
complete profiling of most of the flavonoids (350 nm) (33 compounds 
detected by comparison with standards) was reported by Hasler et al. (26). An 
analysis of 10 commercial Ginkgo biloba samples revealed that in order to 
fulfil the total flavonoid requirement of 24 %, the problems of adulteration 




with rutin existed; and thus the complete profiling method is required for in-
depth quality control (22, 27). 
HPLC-UV methods can also be used for the fingerprinting analysis. Since 
marker analysis may be insufficient, approaches like multi-component or 
fingerprint analyses have been introduced. A fingerprint is a characteristic 
profile or pattern which chemically represents the sample  (20). Fingerprint 
analysis, where the entire chromatogram is analysed, might be a more 
objective approach (28). A difference in quality is not only found in the main 
compounds but also in the low-concentrations compounds (29). As a 
separation technique, HPLC-UV can reduce the sample complexity by 
spreading the information content over the time domain (30). Information 
from individual compounds can be extracted from a chromatographic 
fingerprint (31). 
The fundamental reason of quality control of herbal medicines is based on the 
concept of phytoequivalence of herbs, and then to use this concept to identify 
the real herbal medicine and the false one, as well as to do further quality 
control. Thus, the intuitive evaluation method is to compare the similarities 
and/or differences of the chromatographic ﬁngerprints’ profile (20). HPLC-
UV methods are usually used to compare the fingerprint profiles of closely 
related species or the same species from different locations. This was the case 
for Herba Oldenlandiae, a plant of the Chinese pharmacopoeia, which could 
be adulterated by different Oldenlandia species. A comparative analysis of 
chemical components was obtained by software calculation of correlation 
coefficients of the entire UV chromatograms for appraising similarity (32). 




Fingerprint-based similarity studies can also be employed for 
chemotaxonomic study by applying hierarchical clustering analysis (HCA) 
and principal component analysis (PCA) to a set of HPLC-UV profiles, as was 
performed for different Taxus species (33). 
1.3.2.2 Liquid chromatography with mass spectrometry detection (LC-
MS) 
The use of chromatographic separation with mass spectrometry for the 
chemical characterization and compositional analysis of botanicals has been 
growing rapidly and recognized as a major breakthrough in recent years.  
The overwhelming popularity of HPLC-MS today is largely due to the advent 
of atmospheric pressure ionisation (API) interfaces including electrospray 
ionization (ESI) and atmospheric pressure chemical ionization (APCI). For 
both ESI and APCI, ionization occurs at atmospheric pressure. Certain 
combinations of high voltage and heat are used for the ionization to produce 
the ions that are assayed by the MS system. In ESI, the high-voltage field (3-5 
kV) produces nebulisation of the column effluent resulting in charged droplets 
that are directed toward the mass analyser. These droplets get smaller as they 
approach the entrance to the mass analyser. As the droplets get smaller, 
individual ions emerge in a process referred to as ―ion evaporation‖; these ions 
are then separated by the MS system. In APCI, heat is used to vaporise the 
column eluent, and then a corona discharge is used to ionize solvent molecules, 
which then produce the analyte ions via chemical ionisation mechanisms. 
More recently, a third type of ionization source, termed atmospheric pressure 




photoionisation (APPI), has become available. In APPI, heat is used to 
vaporise the column eluent (similar to APCI), but the ionisation is produced 
by means of an ultraviolet (UV) lamp that produces 10-eV photons. 
Depending upon the solvent system used, the 10-eV photons will ionize either 
the mobile-phase solvent or a dopant (such as toluene) added to the column 
effluent; these ions then produce the analyte ions through various ionisation 
mechanisms including charge or proton transfer (34). 
The mass analyzer, which acts as both the ion transmission device and the ion 
filtering device is another essential module of the MS instrument. For HPLC-
MS applications, many types of mass analyzers can be used. The single 
quadrupole (Q) mass spectrometer is the most commonly used and least 
expensive. For measuring structurally relevant fragments or for very specific 
detection, triple-quadrupole (QQQ) MS systems are the most commonly used. 
They are particularly useful for bioanalytical assays and for specific 
quantification purposes in complex matrices through multiple reaction 
monitoring (MRM) (35). The time-of- flight (TOF) instrument is becoming 
increasingly popular because it provides molecular formula information online 
and has high precision to enable detection of trace analytes,  thus making it the 
preferred technique for the determination of the unknown compounds. Ion-trap 
mass spectrometers have the unique capability of producing multiple-stage 
MS-MS (MSn) data that may be extremely useful for structural elucidation 
purposes (22). 
Over the past decades, mass spectrometry has been revolutionized by 
increasing access to instruments of increasingly high mass-resolving power 




(36). The orbitrap uses only electrostatic fields to confine and analyze injected 
ion populations. Since its introduction, the orbitrap has proven to be a robust 
mass analyzer that can routinely deliver high resolving power and mass 
accuracy. These features make it useful for high performance analyses of 
complex mixtures; its relatively low cost and complexity allows it to be used 
in a variety of laboratory settings (37). Moreover, it has the advantages of full-
scan high sensitivity, wide linear dynamic range and the compatibility with 
high-speed separations. Like the conventional ion traps, orbitrap also has the 
MSn capabilities (38). 
The application of LC-MS in the analysis of herbal plants is widespread 
nowadays. Methods using HPLC-ESI-MS have been applied for the 
identification of components present in Peschiera fuschiaefolia. The alkaloids, 
such as voacamine, voacamidine, vobasine and voachalotine present in P. 
fuschiaefolia were determined using external standard calibration with 
acceptable precision and accuracy. The presence of [M + H]+, [M + 2H]2+ and 
other adduct ions were observed in the positive electospray ionization mode 
(39). Using APCI interface with mass analyzer, such as ion trap or triple 
quadruple instruments, main constituents present in Rhodiola rosea extracts 
and tropane alkaloids from Erythroxylum vacciniifolium could be 
characterized (40, 41). To quickly identify the chemical constituents of 
traditional Chinese medicine formula Chaihu-Shu-Gan-San and to understand 
the chemical profiles related to its antioxidant activity, LC-LTQ-Orbitrap MS 
has been applied for online identification of chemical constituents in such a 
complex system (42). 




1.4 Metabolomics: a global biochemical approach to herbal medicine 
response 
The definition of metabolomics is identification and quantification of all 
metabolites in a biological system, while metabolome is defined as the 
complete set of metabolites in an organism.  Metabolomics is the study of 
metabolism at the global level. This rapidly developing new discipline has 
important potential implications for pharmacology. Metabolomic studies 
capture global biochemical events by assaying thousands of small molecules 
named metabolites in cells, tissues, organs, or biological fluids followed by the 
application of informatics techniques to define metabolomic signatures. 
Metabolomic studies can lead to enhanced understanding of mechanisms for 
herbal medicines or xenobiotic effects (43). 
1.4.1 Metabolomics  
System biology is an emerging field of the biological sciences. Omics is a 
broad discipline of science and engineering for analyzing the interactions of 
biological information objectives in various biological molecules. It includes 
genomics, transcriptomics, proteomics and metabolomics. They are important 
building blocks and will play a central role in omics (see Figure 1.2) (43, 44). 
The integrative analysis of an organism’s response to a perturbation of the 
transcriptome, proteome, and metabolome levels will lead to a better 
understanding of the biochemical and biological mechanisms in complex 
systems. Metabolomics is the endpoint of the omics family and is the closest 
to the phenotype, however currently there is no single instrument platform that 




can analyze all metabolites. Hence metabolomics is an emerging field and 
needs to be developed more deeply and widely. In recent years, more 
researches have been carried out including metabolomics technology 
development, data analysis and storage, integrated studies with other omics 
techniques, as well as metabolomics applications. Moreover, it is 
demonstrated that metabolomics is not just a new member of the omics family 
but a valuable tool to study phenotype and changes in phenotype caused by 
environmental influences, disease, or medicines (44). 
GENOME
• What can happen
TRANSCRIPTOME
• What appears to be happening
PROTEOME
• What makes it happen
METABOLOME










Figure 1. 2 The omics family which describes the response of biological 
systems to drug, disease, genetic and environmental perturbation.  
 
A typical, but simplified workflow for a metabolic fingerprinting analysis is 
shown in Figure 1.3. Samples of interest (e.g., plasma, cerebral spinal fluid, or 




tissue biopsies) are first collected. Small molecules are extracted from these 
samples and are analyzed using techniques that separate and quantitate the 
molecules of interest. Those analytical techniques include liquid and gas 
chromatography, as well as mass and nuclear magnetic resonance 
spectroscopy. Combinations of these techniques can also be used to augment 
separations and/or to obtain further analyte information. The data collected 
from these techniques need to be processed, which may be time-consuming. 
After that, the data are analyzed by one or more software packages designed 
for use with large datasets. Software tools can then be used to do the 




























Figure 1. 3 Simplified workflow for a metabolic fingerprinting analysis.  
 
1.4.2 Metabolomics analysis techniques 
Metabolomics relies on the improvement of analytical techniques and data 
handling systems. Nuclear magnetic resonance (NMR) and mass spectrometry 




(MS) techniques are the most frequently used analytical tools for 
metabolomics, though other analytical techniques have also been applied, such 
as Fourier transform infrared (FTIR) spectroscopy (46-48) and HPLC-UV (49-
51). 
1.4.2.1 NMR spectroscopy 
NMR spectroscopy has played a central role in the understanding of 
metabolism and metabolic processes for more than 30 years. Indeed, the 
application of NMR towards characterizing metabolism dated from the early 
1970s with the use of isotope-tracer analysis to help decipher ethanol 
metabolism (52). The richness of information revealed in these early studies 
soon made NMR a favorite tool for many other metabolic researchers. Since 
that time, NMR has been used in thousands of studies pertaining to microbial, 
plant and animal metabolism using in vivo or in vitro 1H, 13C and 31P NMR 
techniques (53, 54). 
The widespread use of NMR for ―classical‖ metabolic studies, along with its 
exceptional capacity to handle complex metabolite mixtures, also made NMR 
the preferred technology platform for launching the ﬁelds of metabolomics 
(55). While other technologies (e.g., GC-MS and LC-MS) are increasingly 
being used in metabolomics, NMR still has a number of unique advantages. In 
particular, it is non-destructive, non-biased, and easily quantiﬁable; it requires 
minimal sample preparation and permits the identiﬁcation of novel compounds. 
NMR is particularly amenable to compounds that are less tractable to other 
analytical methods (56). 




NMR spectroscopy functions by the application of strong magnetic ﬁelds and 
radio frequency (RF) pulses to the nuclei of atoms. For atoms with either an 
odd atomic number (e.g., 1H) or odd mass number (e.g., 13C), the presence of a 
magnetic ﬁeld will cause the nucleus to possess spin, termed nuclear spin. 
Absorption of RF energy will then allow the nuclei to be promoted from low-
energy to high-energy spin states, and the subsequent emission of radiation 
during the relaxation process is detected (57). The sensitivity depends on the 
natural abundance of the atom studied (1H, 31P, 19F 100%; 13C 1.10%; 15N 
0.37%). As the majority of known metabolites contain hydrogen atoms, 1H 
NMR has been widely employed in metabolomic studies. For 1H NMR, the 
improvements in its sensitivity can be obtained by longer analysis times, 
application of higher magnetic ﬁelds and the use of cryogenic probes (58). 
NMR spectroscopy is a high- throughput ﬁngerprinting technique. Crude 
samples are mixed with a reference-compound solution (e.g., tetramethylsilane 
dissolved in D2O for 
1H NMR), added to an NMR tube, inserted into the 
instrument and analysed. The spectra obtained are complex, containing 
thousands of signals relating to the metabolites. For data processing, the 
spectrum is generally split into buckets of chemical shifts with widths of 0.02-
0.04 ppm. All signals in this bucket are then summed. The chemical shifts can 
be assigned to speciﬁc metabolites and pure metabolite can be added for 
further clariﬁcation (57). 
The technique is used extensively in clinical and pharmaceutical applications 
for the analysis of bioﬂuids or tissues, especially with 1H NMR, e.g. the 
measurement of toxic insults of drugs in rat and mouse urine, including 




paracetomol (59), and determination of bio-markers in coronary heart disease 
of humans (60). The investigation of UV-absorbing vitamin C in the eye by 
metabolomics mapping using 19F NMR after addition of 6-deoxy-6-ﬂuoro-
ascorbic acid has also been reported (61). The study of intact cells or tissues is 
becoming more popular with the application of magic angle spinning (MAS), 
where the sample is rapidly spun (5 kHz) at an angle of 54.7° to overcome the 
difﬁculties of sample heterogeneity and short relaxation times that produces 
resonance broadening and reduces spectral information. This has been applied 
to the analysis of whole cells of the microalga Thalassiosira pseudonana (62). 
In summary, NMR offers essentially universal detection, excellent quantitative 
precision, and the potential for high throughput (> 100 samples/day is 
attainable). The major disadvantage of NMR is its relatively poor sensitivity 
(approximately 1 nmol solute is required). Another disadvantage is its high 
initial cost because NMR instruments can cost well over one million dollars 
(43). 
1.4.2.2 Mass Spectrometry 
MS is also the most widely applied technology in metabolomics, as it provides 
a blend of rapid, sensitive and selective qualitative and quantitative analyses 
with the ability of metabolites identification. Mass spectrometers work 
through 3 processes: 1) ion formation, 2) separation of ions according to their 
mass-to-charge (m/z) ratios and 3) detection of separated ions (57). 
 





GC-MS is a combined system where volatile and thermally stable compounds 
are first separated by GC and then eluting compounds are detected 
traditionally by electron- impact mass spectrometers. In metabolomics, GC-MS 
is a widely accepted method, although it is biased against non-volatile, high-
MW metabolites. Volatile, low-MW metabolites can be sampled and 
subsequently analysed directly, including breath (63) and plant volatiles (64). 
However, the majority of metabolites analysed require chemical derivatisation 
at room or elevated temperatures to provide volatility and thermal stability 
prior to analysis. Hence derivatisation is usually an essential step before GC-
MS analysis. Typically, the exchangeable protons of the metabolites are 
replaced by the functional group of the derivatisation reagents, thus the 
derivatisation products are formed which can be thermally labile. Water is 
usually the bane of derivatisation because it will hinder the esterification 
process during the derivatisation process, so sample drying is important.  
During analysis, small aliquots of derivatised samples with the injection 
volumes of around 1 µL are analysed by split and splitless techniques on GC 
columns of differing polarity (DB-5, DB-50 or similar stationary-phase 
capillary columns are most commonly used). These provide both high 
chromatographic resolution of compounds and high sensitivity with typical 
limits of detection of pM or nM. The chromatograms obtained are complex, 
containing hundreds of metabolite peaks. The alignment of these raw data can 
then be performed. Quantification is provided by either external calibration or 
response ratio (peak area of metabolite divided by peak area of internal 




standard). External calibration is labour intensive and not all metabolites are 
commercially available to enable preparation of standard solutions. Metabolite 
identification is provided by matching the retention time and mass spectrum of 
the sample peak with those of a pure compound previously analysed on the 
same or different instrument under identical instrumental condit ions (65). 
However, many metabolites are not available commercially, so the 
commercial GC-MS database is more widely employed. In case the 
commercially available mass spectral databases do not contain the information 
of the specific metabolites, structural identification can be performed via 
interpretation of fragment ions and fragmentation patterns because the electron 
impact mass spectrometer provides standard fragmentation of molecular ions 
during ionisation. 
As a mature analytical technique, GC-MS has already been in widespread 
application in metabolomics. The first applications of GC-MS in 
metabolomics can be traced to urinary screening procedures to indicate the 
presence of diseases related to organic acidemias (66). Recently, applications 
in plant metabolomics including Arabidopsis (67), potatoes (68) and tomatoes 
(69) have all been studied to measure effects of genetic or environmental 
modifications and stressors. The microbial and clinical metabolomics of 
biofluids and breath are now carried out (70-72). GC×GC-TOF-MS can 
provide better sensitivity, resolution and reproducibility and has been used in 
the measurement of targeted metabolites of Methylobacterium extorquens 
AM1 growth on two different carbon sources (73); meanwhile the distance 




and spectrum correlation optimization alignment (DISCO) for this two-
dimensional technique based metabolomics has been proposed (74). 
1.4.2.2.2 LC-MS 
Another commonly used hyphenated technique is LC-MS. Compared to GC-
MS, it needs lower analysis temperature and the sample preparation is easier 
without the derivatisation step. Usually sample preparation is simply carried 
out by extraction and/or protein precipitation (e.g., tissue samples) by dilution 
in an appropriate solvent. In LC, different columns are often used in order to 
separate a wide range of compounds with different chemistries and 
quantitation may be variable due to variability in ionization and ion 
suppression effects (75). In addition, metabolite identiﬁcation is more time 
intensive. Unlike GC-MS, LC-MS does not have the commertially available 
database. However, with the use of accurate mass measurements and/or 
tandem MS (MS/MS) to provide collisional induced dissociation (CID) and 
related mass spectra, metabolite identiﬁcation can be performed (76). 
The application of LC-MS based metabolic ﬁngerprinting includes the 
analysis of urine samples in toxicity studies (77, 78) or genetic studies (79), 
plasma samples (80), plant extracts (81) and the analysis of fungal metabolites 
(82). With a wide range of columns that are available, and developments in 
LC such as two dimensional LC, ultra-high performance LC (UPLC), ultra-
fast LC (UFLC), the applications of LC-MS in metabolomics are poised to 
increase. 
 




1.4.2.2.3 Other MS-based techniques 
Direct- injection mass spectrometry (DIMS) is known to be a high-throughput 
screening tool as it is reported that the running time for each sample is as short 
as 1 min and hundreds of samples could be analysed per day. Crude sample 
extracts are injected or infused into an electrospray mass spectrometer 
resulting in one mass spectrum per sample, which is representative of the 
composition of the sample (57). Applications of DIMS are mainly 
concentrated in the microbial (83) and plant studies (84). In clinical 
applications, DIMS with MS/MS has been used in disease diagnosis (85). 
Although DIMS is a high-throughput metabolic ﬁngerprinting technique, it has 
several disadvantages. For example, chemical isomers which have the same 
exact mass cannot be distinguished by this rapid screening technique (44). 
Another area of growing interest is the application of matrix-assisted laser 
desorption ionisation (MALDI), laser desorption ionisation (LDI) or direct 
ionisation on silicon (DIOS) to provide ionisation of metabolite solutions 
spotted directly on a target plate, so allowing minimal sample preparation and 
high- throughput analysis. As a hyphenated technique, capillary 
electrophoresis-mass spectrometry (CE-MS) can provide both the metabolite 
separation and identification and it has signiﬁcant potential to be employed in 
analyzing the metabolome (86). In the last few years, both high-resolution 
separation and sensitive detection methods have shown the ability to detect up 
to 1600 metabolites in positive and negative ion modes (57). 
 




1.4.3 Metabolomics data analysis 
The statistical tools for metabolomics data analysis could be generally 
classified into unsupervised methods and supervised methods. Unsupervised 
methods such as hierarchical clustering analysis (HCA), principal component 
analysis (PCA), or independent component analysis (ICA) are used for sample 
classiﬁcation under the circumstance that prior information about the sample 
identity is unknown. Otherwise, supervised methods such as partial least 
square (PLS) or soft- independent method of class analogy (SIMCA) should be 
chosen (44). 
The most popular data analysis tool in metabolomics is PCA which is 
available in many statistical software packages; and PCA score plots have 
become iconic of the metabolomics research report. PCA is a statistical 
method that reduces a great number of variables into a smaller number of 
uncorrelated variables, which are called principal components. The ﬁrst 
principal component explains the greatest variability in the data, the second 
principal component is independent of, or orthogonal to the ﬁrst component 
and second best explains the variability of the data and so on. The goal of the 
exercise is dimensional reduction, while sacriﬁcing as little accuracy as 
possible. In a typical analysis, several hundreds variables representing one 
spectrum are reduced to two or three variables, which can be demonstrated as 
a single point in two-dimensional or three-dimensional plots. This means that 
each point on a metabolomic PCA score plot represents all the data contained 
in one spectrum. Sample points that cluster together have more s imilar spectra. 
The PCA data can then be examined in more details by examining the loading 




plots. ―Scores‖ indicate the relationships between samples, while ―loadings‖ 
indicate the correlations between the variables. From the loading plots, the 
variables which are primarily responsible for separation can be identified, thus 
spectral regions/peaks can be identiﬁed and speciﬁc compounds could then be 
postulated. PCA plots are extremely powerful for rapid identiﬁcation of 
inherent clusters in the data which may be suggestive of a common effect or 
mechanism (87). 
1.4.4 Metallomics 
1.4.4.1 Metallomics and metallome 
Metallomics is an emerging research area and is proposed as the 
interdisciplinary field for the promotion of biometal science. In order to gain 
an insight into the scientific field of ―metallomics‖, a schematic model of the 
biological system is illustrated in Figure 1.4, where the biological cell and the 
biological fluids (e.g., blood serum) are separated by the cell membrane. On 
the left hand side, academic terms such as genomics, proteomics and 
metabolomics are shown along with metallomics to indicate their research 
areas in the biological system.  
Many biological substances as well as metal ions are transported as raw 
materials inside the cell through the membrane. In general, material 
conversion is actively occurring inside the cell and also often in the cell 
membrane, and such material conversion and transportation processes out of 
the cell are called ―metabolism‖. Biological substances, which are metal ions 
produced in metabolism, have been called ―meta llome‖ (88).  




Bio-sciences concerned with metallic elements and their applications have 
been studied independently in many scientific fields such as biochemistry, 
bioinorganic chemistry, nutritional science, pharmacy, medicine, toxicology, 
agriculture, environmental science and so forth. From the viewpoint of 
biological science, all such scientific fields have a deep interrelationship with 
the common theme of ―metals‖. Therefore, it is desirable that biometal science 
is promoted as the interdisciplinary field to integrate the metal- related 
scientific fields.   
 
Figure 1. 4 A schematic model of the biological system, showing the 
relationships among genomics, proteomics, metabolomics and metallomics, 
where metallic ions are shown as M. 
 
1.4.4.2 Analytical techniques in metallomics study 
In the study on the subjects in metallomics, many advanced analytical 
techniques are needed to explore the new research fields for integrated 




biometal science. ICP-MS is a type of mass spectrometry that is capable of the 
determination of a range of metals at concentrations below part per trillion 
levels. In trace elemental analysis, this method has advantages of high speed, 
precision and sensitivity. So far, the hyphenated techniques such as LC-ICP-
MS, GC-ICP-MS and LC-ICP-AES (Atomic Emission Spectroscopy) have 
been developed as the analytical methods for chemical speciation of trace 
metals in the biological samples. Such hyphenated methods are actually the 
most powerful techniques for chemical speciation. However, they are useful 
only for the identification of known and stable compounds such as 
methylmercury, methylated arsenics, butyltin compounds and so on (89, 90). 
However, from recent developments, it is obvious that the identification of 
biomolecules, such as metalloproteins and metalloenzymes, as well as metal-
binding nucleic acids and metabolites, will become more important in 
exploring biometal science in relation to their biological functions and 
metabolism. Subsequently, the methods for the direct identification of 
biomolecules, such as electrospray mass spectrometry (ES-MS) and matrix-
assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-
TOFMS), should be employed for the study on chemical specition (91, 92). 
1.5 Research scope 
The primary objective of this dissertation is to expand the analytical 
applicability of sample preparation and detection methods to the evaluation of 
toxicity and quality control of herbal medicines and develop metabolomic and 
metallomic approaches for the evaluation of the effect of herbal medicines in 
hyperchlesterolemic rat model.  




Pyrrolizidine alklaoids (PAs), widely distributed in herbal medicines around 
the world, were investigated first. The recent success with the use of LC-ESI-
MS for the analysis of constituents in complex botanical extracts suggests that 
this technique could be effective for both the qualitative and quantitative 
determination of pyrrolizidine alkaloids in botanical extracts. Hence, one of 
the aims of the current work was to develop a new method based on HPLC ion 
trap and orbitrap MS with electrospray ionization interface for the qualitative 
analysis of hepatotoxic PAs such as lycopsamine present in Symphytum 
officinale L.. Another aim of the present study was to perform quantitative 
determination of lycopsamine present in comfrey. For this purpose, proper 
sample preparation was of utmost importance. Therefore, comparative studies 
on different extraction methods, including sonication, pressurized hot water 
extraction (PHWE) and heating under reflux were performed prior to 
quantitative analysis by LC-MS. 
Then the quality control of various Chrysanthemums was studied. The aim of 
this work was to develop an economical and effective quality control approach 
using green-solvent methods based on PHWE for the extraction of varieties of 
chrysanthemums combined with simple and high throughout HPLC-UV for 
detection. Under the optimum conditions, the extraction efficiency of PHWE 
was evaluated by comparing it with vortex extraction and extraction by 
heating under reflux. For data analysis, Principal Component Analysis (PCA) 
was applied to study the classification and separation of different varieties of 
chrysanthemum according to uses, species, provenance and quality. To show 




that PHWE is practical and effective as a green method, PFE with methanol 
was also carried out using the same procedure for comparison.  
Next, the effect of berberine, a commonly used herbal medicine, was 
evaluated through metabolomic approach in hypercholesterolemic rat model. 
In this study, we reported the effect of berberine at a dosage of 50 mg/kg on 
the serum and liver cholesterol from male Sprague Dawley rats fed with a high 
fat and high-cholesterol (HFHC) diet. In addition, the current approach based 
on GC-MS and 1H NMR was used to study the metabolic profiles in the liver, 
serum, heart and kidney samples associated with the weight loss and 
cholesterol lowering effects of berberine in the livers of Sprague Dawley rats. 
Finally, a set of appropriate biomarkers associated with the metabo lism of 
berberine in the tissue samples collected would be identified.  
Lastly, a combined metabolomic and metallomic investigation of profile 
changes in rat urine and blood serum induced by Berberine (BBR) in 
hypercholesterolemic Sprague Dawley rats was carried out. The approach 
involves the use of 1H NMR for the analysis of rat urine to achieve metabolic 
fingerprinting and the use of inductively coupled plasma – mass spectrometry 
(ICP-MS) for the analysis of rat blood serum to achieve metallic fingerprinting. 
The combination of metabolomics and metallomics was expected to make 
deeper and broader understanding of the berberine effect on rats. As the 
concentration of endogenous metabolites in urine vary widely based upon 
water consumption and other physiological factors like health and body mass, 
the normalization approaches including normalization to creatinine and total 
intensity of each 1H NMR spectrum were investigated and compared.  




The entire dissertation will be divided into two parts: Part I will focus on the 
toxic compounds determination and quality assessment of herbal medicines, 
and Part II will focus on metabolomic and metallomic studies for the 










TOXIC COMPOUND DETERMINATION AND QUALITY 
ASSESSMENT 




Chapter 2 Determination of Pyrrolizidine Alkaloids in 
Comfrey by Liquid Chromatography-Electrospray Ionization 
Mass Spectrometry 
2.1 Introduction 
Symphytum officinale L. (comfrey) is a well known herb that has been used 
extensively to treat a wide variety of aliments such as arthritis, varicose ulcers 
and sprains. In addition, it is also consumed in tea form or as part of dietary 
supplements. Unfortunately, this herb is also potentially toxic and has been 
mentioned in monographs on poison plants (93). The toxins in comfrey 
include pyrrolizidine alkaloids (PAs), such as lycopsamine, echimidine and 
lasiocarpine (Table 2.1), and their N-oxides. PAs are of special interest 
currently because several of them have been shown to cause toxic reactions in 
humans, primarily veno-occlusive liver disease, when ingested as food or 
herbal medicines. For this reason, it is necessary to monitor the concentration 
of toxic PAs and researchers have highlighted essential analytical 
requirements for confident assessment of pyrrolizidine alkaloid-related safety 
of food and herbal products (94). As their occurrence is widely distributed, it 
is important to develop rapid methods for their qualitative and quantitative 








Table 2. 1 Some pyrrolizidine alkaloids in Symphytum officinale L.  





















































































For the chemical standardization of botanicals and herbal preparations, the 
extraction of bioactive components or marker compounds is an important step. 
The methods found in the monographs of Pharmacopeias and other reports (95, 
96) often use extraction methods that require significant volume of organic 
solvents and are rather tedious. In previous PAs extraction studies, the use of 
methanol at temperature 50-60°C for 12h was often recommended (97). The 
best result of extraction of PAs from comfrey was obtained using 1% 

























temperature 100 ± 5°C for 2 h (98). Recently, simpler and more environmental 
friendly extraction methods have been developed. These include supercritical 
fluid extraction (SFE), microwave-assisted extraction (MAE), and pressurized 
fluid extraction (PFE) (3, 99). Pressurized hot water extraction (PHWE) is 
another new extraction technique which can be applied for the isolation of 
bioactive or marker compounds from botanicals and medicinal plants (12). It 
is effective for a wide range of analytes and matrices because the physico-
chemical properties of water are readily altered through changes in 
temperature and pressure. The applied temperature is the main parameter 
affecting extraction efficiency and selectivity (12). Pressure is usually applied 
to maintain water in the liquid phase, and its effect on the extraction efficiency 
is usually not significant. To our best knowledge, the application of PHWE on 
comfrey is limited. 
Methods based on GC-MS and LC-MS have been reported for the detection of 
PAs due to their sensitivity and specificity (100-105). However, GC-MS is not 
very suitable for the analysis of PA N-oxides due to their thermal instability. A 
pre-reduction of the N-oxides followed by derivatization is required if analysis 
is to be done by GC-MS. For these reasons, LC-MS is the preferred method in 
our study. LC-MS analysis of macrocyclic PAs in Senecio spp. using 
thermospray interface was previously reported (106, 107). Lin et al. (100), 
analysed various types of macrocyclic PAs with both in-source (collision 
induced dissociation in the collision cell) and out-source HPLC-MS or HPLC-
MS/MS using electrospray interface. Mroczek et al., performed structure 
characterization of PAs in various plant species by RP-HPLC ion trap MS 




method with atmospheric pressure chemical ionization (APCI) interface (108) 
and gradient HPLC with diode array (DAD) and thermabeam electron impact 
(EI) MS (109). Till now, HPLC ion-trap and orbitrap MS with electrospray 
ionization interface has not been used in the determination of PAs in comfrey.  
The recent success with the use of LC-ESI-MS for the analysis of constituents 
in complex botanical extracts suggests that this technique can be effective for 
both the qualitative and quantitative determination of pyrrolizidine alkaloids in 
botanical extracts. Hence, one of the aims of the current work is to develop a 
new method based on HPLC ion trap and orbitrap MS with electrospray 
ionization interface for the qualitative analysis of hepatotoxic PAs such as 
lycopsamine present in Symphytum officinale L.. Another aim of the present 
study is to perform quantitative determination of lycopsamine present in 
comfrey. For this purpose, proper sample preparation is of utmost importance. 
Therefore, comparative studies on different extraction methods, including 
sonication, pressurized hot water extraction (PHWE) and heating under reflux 
were performed prior to quantitative analysis by LC-MS.  
2.2 Materials and methods 
2.2.1 Chemicals and reagents  
All reagents were of HPLC grade. Methanol was the product of Merck 
(Nordic European center, Singapore). Ethanol, chloroform, isopropyl alcohol 
were purchased from Fisher scientific (Loughborough, Leicestershire LE11 
5RG UK). Acetonitrile was the product of Tedia (Fairfield, OH45014, USA). 
Formic acid was obtained from Fluka (Sigma-Aldrich Pte Ltd, Science Park II, 




Singapore). Lycopsamine was purchased from Planta Analytica (USA), 
echimidine and lasiocarpine were purchased from Phyto Lab (Germany). Sand 
(white quartz, 50-70 mesh) was purchased from Sigma (St. Louis, MO, USA). 
Ultra-pure water was obtained using an Omega NANOpure ultrapure water 
system (Barnsteas Int., Dubuque, IA, USA). The plant comfrey of Symphytum 
officinale L. was kindly provided by University of Quindío, Colombia.  
2.2.2 Preparation of reference standards 
Stock solutions of lycopsamine, echimidine and lasiocarpine at 200ppm were 
prepared in methanol. For all analysis, the working solutions of lycopsamine, 
echimidine and lasiocarpine were prepared in the range of 0.05–2ppm in 
methanol and their linearity was determined. For the quantitation of marker 
compounds, a four-point calibration based on the linearity established were 
used. 
2.2.3 Preparation of medicinal plants  
To prepare a homogenous sample, the dried comfrey was ground using an 
IKA MF10 microfine grinder (Staufen, Germany) with sieve insert of hole size 
0.5 mm. For PHWE, 1 g of the comfrey sample was weighed directly into a 
glass tube and mixed thoroughly with a high proportion of sand. The sand and 
plant material mixture were transferred into the extraction cell for PHWE as 
mentioned below. The extraction cell was finally filled with sand to avoid any 
voids. 
2.2.4 Extraction 




2.2.4.1 Sonication Extraction 
Briefly, 1 g of ground comfrey sample was extracted with 50 mL of solvent 
(methanol/water (50:50), methanol/chloroform (15:85), methanol, and ethanol) 
at room temperature for 10 min and filtered. The extracts were obtained, then 
excess solvent was evaporated with the rotary evaporator and the residues 
were transferred into a 10mL volumetric flask.  
2.2.4.2 Extraction by heating under reflux 
1g comfrey was weighed into a round bottom flask. Then 60mL 
methanol/water (50:50) was added and the mixture was gently refluxed at 
65°C for 1h in an electromantle before centrifuge at 2000rpm for 10min to 
isolate the extract. Excess solvent was evaporated on the hotplate and the 
residues were transferred into a 50mL volumetric flask.  
2.2.4.3 Pressurized hot water extraction (PHWE) system 
For the instrumentation used for PHWE, the stainless steel tubings were 1/16 
inch OD and 0.18mm ID. The extraction cells from Phenomenex were of 
stainless steel with 10mm ID × 1/2 inch OD × 250mm (approx. 17 ml). The 
extraction cell was heated in a HP5890, gas chromatograph oven (Hewlett 
Packard, USA). The pump used was a Shimadzu LC-10AT HPLC pump 
(Kyoto, Japan). The pump flow was set at 1.5 mL/min and the oven 
temperature from 60°C to 120°C was studied. The pressure in the system 
indicated by the HPLC pump was between 20 and 30 bar. The extraction cell 
was pre- filled with methanol/water (50:50) to check for possible leakage 




before setting the temperature of the oven to the required value. Extraction 
with methanol/water (50:50) was carried out for a period of 40 min and 60–70 
ml of liquid was collected. In between runs, the system was washed with 
methanol/water (50:50) for 5 min. The excess liquid was evaporated with the 
rotary evaporator under vacuum or by heating on a hotplate to 20–25 ml, and 
the residues were transferred into a 50 ml volumetric flask.  
2.2.5 LC-MS analysis 
Before HPLC analysis, all the real samples were filtered using the Acrodisc 
32mm Syringe filters with 0.2μm Supor membrane (Pall Newquay, Cornwall, 
UK). For quantitative analysis, the LC-ESI-MS system comprised an Agilent 
1100 series (Waldbronn, Germany) binary gradient pump, autosampler, 
column oven, diode-array detector and a LCQ-Duo ion trap mass spectrometer 
(Thermo Finnigan, San Jose, CA, USA). The column used for the separation 
was a Luna C18 (2), 100×2.0mm, 3μ (Phenomenex, USA). The gradient 
elution consisted of mobile phase of (A) water with 0.1 % formic acid and (B) 
acetonitrile with 0.1 % formic acid. The initial condition was set at 5% of (B), 
gradient up to 100% in 15 min and returning to the initial condition for 10 min.  
Oven temperature was set at 40°C and flow rate was set at 0.2mL/min. For all 
experiments, 5μL of standards and sample extracts were injected. ESI-MS was 
performed in the positive mode. The LCQ mass spectrometer was operated 
with the capillary temperature at 270°C, sheath gas at 80 (arbitrary units) and 
auxiliary gas at 20 (arbitrary units). The target was fixed at 2×107 ions and the 
automatic gain control was turned on. The electrospray voltage was set at 4.5 




kV, the capillary voltage at 10V and lens tube offset at 0V. Mass spectra were 
recorded from m/z 100–600. 
2.2.6 LC-MSn analysis 
For qualitative analysis of PAs and N-oxides, LC-MSn experiments were 
performed using a Thermo Finnigan (San Jose, CA, USA) LTQ Orbitrap 
hybrid mass spectrometer coupled to a Thermo Finnigan Surveryor micro 
autosampler and liquid chromatography system. The extract was injected onto 
a Waters Symmetry 300 C18 column (3.5 µm, 2.1 × 50 mm ID). The mobile 
phase consisted of (A) 10 mM ammonium acetate and (B) acetonitrile. The 
gradient for elution was as follows: 0-5 min: 5% B; 5-15 min: 5-40% B; 15-30 
min: 95% B; 30-45min: 5% B. Flowrate was 0.2 mL/min.  
The mass spectrometer was equipped with an electrospray interface as 
ionization source, an ion trap and an orbitrap for MSn experiments and high 
mass accuracy determination. The mass spectrometer was operated in the 
positive mode with the following conditions: sheath gas N2 with flow of 45 
L/min; auxiliary gas at 5 L/min; sweep gas at 3 L/min; spray voltage, 4 kV; 
source current, 100A; capillary temperature, 400C; capillary voltage, 50 V; 
tube lens, 120 V. Full-scan mass spectra (50-500 amu) were recorded every 50 
ms. 
For MS/MS experiments, the conditions were: isolation width, 1 amu; 
normalized collision energy, 25%; activation time, 30 ms. The protonated 
parent ion [M + H]+ of the PAs and N-oxides were chosen as precursor ions 
for isolation and fragmentation.  




For MS3 experiments, the conditions were: isolation width 1 amu; activation 
time, 30ms; normalized collision energy, 25-35%. The most intense product 
ions with m/z greater than 150 (excluding parent ions) were chosen as 
precursor ion for isolation and fragmentation.  
2.3 Results and discussions 
2.3.1 Separation and determination of PAs in comfrey extracts  
In other reports (101), one of the problems encountered in the development of 
a method to characterize the PAs in Symphytum officinale L. was the lack of 
commercial standards. Using the HPLC conditions stated above, the three 
standards of lycopsamine, echimidine and lasiocarpine were separated well 
and their retention times were 2.82, 9.10 and 9.63min respectively. In positive 
ion ESI experiments, lycopsamine, echimidine and lasiocarpine form [M+H]+ 
at 300.2, 398.2 and 412.0 respectively. Figure 2.1 showed the selected ion 
chromatogram of lycopsamine, echimidine and lasiocarpine in their standard 
mixture solution (Figure 2.1a) and comfrey extracts (Figure 2.1b) respectively. 
As lycopsamine could be clearly identified from comfrey extracts, it will be 
quantitated in the following extraction study. Linearity was established from 
0.05ppm to 2ppm, and their linear correlation coefficients r2 were 0.999. The 
system precision (RSD) for the analysis of lycopsamine, echimidine and 
lasiocarpine by this method was determined at the concentration level 0.1, 1, 
2ppm and the results showed in Table 2.2 were found to vary between 2.06 
and 9.21%.  




























































































































































































Figure 2. 1 Spectra under SRM of lycopsamine, echimidine and lasiocarpine 
in their standard mixture solution (a) and comfrey extracts (b); peak 
identification of (a): tR=2.82min (lycopsamine); tR=9.10min (echimidine); 
tR=9.63min (lasiocarpine); peak identification of (b): tR=2.80min (lycopsamine) 
 
 




Table 2. 2 RSD (n=6) values of LC-MS method for determination of 
lycopsamine, echimidine and lasiocarpine 
Compounds Concentration (ppm)  RSD (%) 
Lycopsamine 2.0 4.25 
1.0 2.06 
0.1 9.21 
Echimidine 2.0 3.45 
1.0 5.29 
0.1 2.32 




2.3.2 LC-MSn analysis of PAs  
LC combined with MSn detection can provide mass-based resolution of the 
PAs based on the specific product ions or fragments that arise from the MSn. 
LC-MSn with its low detection limit also allows the detection of trace amounts 
of PAs present. The results of the MSn experiments for lycosamine, echimidine 
and lasiocarpine standards were summarized in Table 2.3 (mass spectrum not 
shown). All the three PAs contain the fragment, m/z 120, which is a 
characteristic of the retronecine moiety, the basic structure which they are 
derived from (110). In comfrey extracts, lycopsamine was detected and its 
MS2 spectrum was showed in Figure 2.2a. As can be seen from the 
fragmentation pathway, lycopsamine showed characteristic fragment ions at 
m/z 120.0806 and 138.0912, which were characteristic fragmentation ions of 
retronecine-type alkaloids (110). In addition, mass spectral analysis has 
revealed some common fragmentation pathways that are shared by the PAs 




based on some of the product ions that they gave rise to. One of the 
fragmentation pathways that occur commonly among PAs is the McLafferty 
rearrangement (101, 104), and the fragment ion at m/z 256.1546 was 
presumed as the product of this rearrangement.  





























, 156 - 












































Figure 2. 2 (a) Positive MS2 spectrum of lycopsamine extracted from 
Symphytum officinale L., product ion of [M + H]+ at m/z 300.18 and 
fragmentation pattern of lycopsamine; MSn with m/z 398.22 extracted from 
Symphytum officinale L. (b) MS2 of [M + H]+ 398.22, (c) MS3 of m/z 254.10; 
and MS2 of PAs with m/z 382.22 extracted from Symphytum officinale L.; and 
(d) MS2 with m/z 382.22 extracted from Symphytum officinale L. 
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In the analysis of [M + H]+ at 398.22, two compounds share the same 
protonated molecular weight, the N-oxides of symviridine and the PAs of 
echimidine. Both share similar structure except that the R3 of echimidine is a 
hydroxyl group instead of a hydrogen atom (Table 2.1).  MS2 of the 
echimidine standard produced fragments of m/z 120, 220, 336, and 380 with 
m/z 220 being the most intense. The fragment m/z 336 was derived from 
McLafferty rearrangement with the loss of a water molecule ([M+H]+ - 44 -
18). However, by comparing the MS2 and MS3 spectra that arose from m/z 
398.22 (Figure 2.2 b and c) with that of the echimidine standard, it was found 
that the MSn data did not match with that of the standard. By prediction, MS2 
of the N-oxides of symviridine via McLafferty rearrangement would give rise 
to the product ion m/z 354 (no water molecule is lost due to R3 being 
hydrogen instead of hydroxyl) which was what was detected in the spectrum. 
A further confirmation was obtained by performing a selected reaction 
monitoring (SRM) experiment on the parent/daughter ion pair of m/z 
398.22/336 to determine the presence of echimidine. The result obtained 
suggested that echimidine was absent in Symphytum officinale L. extract and 
the mass spectra in Figure 2.2 b and c were attributed entirely to the N-oxides 
of symviridine. Additionally, the PAs of symviridine were also detected in 
comfrey extracts and the MS2 spectrum is shown in Figure 2.2 d. In the 
analysis of [M + H]+ at 412.23, the absence of lasiocarpine was also confirmed. 
Thus, only lycopsamine among the PAs standards was detected in comfrey 
extracts. Hence in the subsequent quantitative work, lycopsamine analysis 
would be focused on. 




2.3.3 Extraction of comfrey 
2.3.3.1 Sonication Extraction of Comfrey 
Solvent has a significant effect on the extraction efficiency of PAs in comfrey 
(111) and the main aim of sonication extraction in this work is to choose the 
most appropriate solvent for lycopsamine extraction from comfrey. Hence, the 
effect of solvent was evaluated by using methanol/water (50:50), 
methanol/chloroform (15:85), methanol and ethanol and the results were 
showed in Figure 2.3a. It is obvious that more amount of lycopsamine can be 
obtained while using methanol/water (50:50) compared to the other solvent. 
Hence, methanol/water (50:50) was selected as the optimum solvent for the 
subsequent studies. The effect of solvent pH was next investigated. 
Hydrochloric acid was added for the preparation of acidified solvent 
methanol/water (50:50) (HCl, pH=2.51). Figure 2.3b showed that comparable 
amounts of lycopsamine were extracted using both the acidified and non-
acidified solvent. Hence, there is no need to use the acidified solvent in the 
extraction of PAs from comfrey.  
 
 






















































































































































Figure 2. 3 (a) Effects of solvent on the amount of lycopsamine extracted 
from comfrey by sonication. Extraction solvent: a1-methanol/water (50:50), 
a2-methanol/chloroform (15:85), a3-methanol, a4-ethanol (n=3); (b) pH 
Effects of solvent on the amount of pyrrolizidine alkaloids extracted from 
comfrey by sonication. Extraction solvent: b1-methanol/water (50:50), b2-
methanol/water (50:50) (HCl, pH=2.51) (n=3). Other sonication extraction 
conditions: time, 10min; temperature, 25°C. 
 
2.3.3.2 Pressurized Hot Water Extraction (PHWE) of comfrey  
To further improve the extraction efficiency and to reduce the extraction time, 
a new and rapid technique for the extraction of target compound s from 
comfrey based on PHWE was investigated. The key parameters that would 
have a significant effect on the extraction efficiency of PHWE was the applied 
temperature (13, 112, 113). Hence, the effects of temperature from 60 to 
120°C on the extraction efficiency of lycopsamine in comfrey were studied 
and the result (Figure 2.4a) showed that the amount of lycopsamine decreased 
with the increasing temperature. It was proposed that the presence of dissolved 
gases in the subcritical solvent may have caused the oxidation of lycopsamine 
in comfey at a higher applied temperature. And therefore, 60 oC was selected 
as the optimum temperature since the highest amount of lycopsamine was 




extracted out. The time for extraction was set at 40 minutes as it was observed 
that a significant amount of target analytes would be extracted in the first 







































































































































































































































































































Figure 2. 4 (a) Effects of temperature on the amount of lycopsamine extracted 
from comfrey by PHWE (n=3); and comparison of amount of lycopsamine 
extracted from comfrey by PHWE and heating under reflux (n=6): (b) PHWE 
(60°C) Vs. Reflux, day 1, (c) PHWE (60°C) Vs. Reflux, day 2 and (d) PHWE 
(80°C) Vs. Reflux. PHWE conditions. PHWE conditions: solvent, 
methanol/water (50:50); flow rate, 1.5ml/min; time for extraction, 40min.  
 
2.3.3.3 Extraction of comfrey by heating under reflux  
Due to the intrinsic property of plant extraction by PHWE, its extraction 
efficiency could be evaluated by comparing with other methods such as 
Soxhlet extraction, heating under reflux and others (14, 115, 116). In this 




study, a comparison of PHWE with heating under reflux was carried out and 
the results obtained are showed in Figure 2.4b-d and Table 2.4. For PHWE at 
60°C and 80°C, the amount of lycopsamine was comparably lower than that 
obtained by heating under reflux. The reason for the lower extraction 
efficiency of PHWE was presumably due to the reduction in solubility of 
lycopsamine in the pressurized hot solvent caused by the dissolved nitrogen of 
air (117). The results observed in the current work was consistent with our 
earlier work (115) where certain naturally occurring compounds in medicinal 
plants was observed to be degraded in hot pressurized water rather than hot 
water due to the high reactivity of hot pressurized water (118). 
However, in one of our other studies on the extraction of senkirkine and 
senecionine from Tussilago farfara by PHWE, a comparable extraction 
efficiency was obtained (119). Although senkirkine, senecionine and 
lycopsamine all belong to hepatotoxic pyrrolizidine alkaloids, their extraction 
efficiencies by PHWE vary significantly. It proves that PHWE is not a 
universalizable technique and the use of subcritical water for extractions 
depends on the physical properties of the dissolved solutes and their tendency 
to degrade under the chosen extraction conditions (117). Concurrently, the 
method precision (RSD) of both the two methods was found to vary from 
2.49% to 19.32% (Table 2.4) respectively. The proposed reason of the 
relatively high RSD may be that lycopsamine is not stable enough under 
pressurized hot water conditions, its solubility may be affected by dissolved 
gases, and its content in comfrey is quite low. As a result, though PHWE is a 
more rapid method, heating under reflux was found to be more appropriate for 




the extraction of lycopsamine from comfrey in quantitative analysis 
considering its higher extraction efficiency.  










Comparison 1  Comparison 2  Comparison 3 
PHWE (60°C) 
Day 1 (n=6) 
Reflux 
(n=3) 
 PHWE (60°C) 
Day 2 (n=6) 
Reflux 
(n=3) 




Mean ± S.D. 13.88 ± 2.68 31.73 ± 1.70  13.59 ± 1.30 30.87 ± 4.08  9.72 ± 1.25 29.15 ± 0.73 









2.4 Concluding remarks 
The combination of HPLC with orbitrap mass spectrometry allows for the  
rapid and accurate determination of pyrrolizidine alkaloids such as 
lycopsamine in botanical extracts. At the same time, the MSn spectra gave 
characteristic ions that are useful for the identification of PAs in unknown 
samples. Subsequently, quantitative analysis of lycopsamine in comfrey was 
carried out, which has seldom been reported previously. The extraction of 
lycopsamine from comfrey was studied by evaluating different methods, 
including sonication extraction, pressurized hot water extraction and hea ting 
under reflux. The results obtained showed that LC-ESI-obitrap MS provided a 
powerful method for the identification and determination of hepatotoxic 
pyrrolizidine alkaloids in botanicals and dietary supplements. In addition our 
results showed that extraction of comfrey was more effective by heating under 
reflux compared with PHWE. Our results also provided new insights into the 
understanding and practical application of PHWE. 




Chapter 3 A green and effective approach for characterization 
and quality assessment of Chrysanthemum  by pressurized hot 
water extraction in combination with HPLC with UV 
absorbance detection 
3.1 Introduction 
Chrysanthemums are a genus (Chrysanthemum) of about 30 species of 
perennial flowering plants in the family Asteraceae, native to Asia and 
northeastern Europe. Modern chrysanthemums have a wide range of uses, such 
as traditional Chinese medical uses, ornamental uses and culinary uses. 
Chrysanthemum as a common ingredient in Traditional Chinese Medicine 
(TCM) can dispel wind-heat, subdue hyperactivity of the liver, and improve 
eyesight (120-122). Studies showed that chlorogenic acid and flavonoids such 
as luteolin and apigenin, which were able to give the same effect as 
chrysanthemum, were the actual bioactive constituents of chrysanthemum. 
Therefore, the determination of these three compounds could be used in the 
practice of chrysanthemum quality control (121, 123). However, the restriction 
of targeted analysis to specific metabolites results in missing a large part of the 
molecular information pertained in the metabolome of a kind of 
chrysanthemum, thus limiting its analytical significance. To overcome this 
limitation, a more comprehensive strategy such as the use of chemical 
fingerprinting for effective analysis and discrimination is needed.  




Chemical fingerprinting has been accepted by the World Health Organization 
(WHO) and United States Food and Drug Administration (FDA) as a strategy 
for the assessment of the quality of botanicals (124). A chemical fingerprint of 
a botanical extract is a chromatogram representing all the detectable chemical 
components present in the extract being separated as much as possible for 
identification and characterization of that botanical (125). With the aid of 
pattern recognition tools such as Principal Component Analysis (PCA), 
chemical fingerprinting has been proven to be a useful strategy for the quality 
control of botanicals (124, 126). Due to the large number of samples involved 
in chemical profiling, methods that are simple and yet with high throughput 
capabilities are favorable. Hence, HPLC-UV was chosen as the separation 
technique. 
The scientific interest in finding fast, effective, economical and environment-
friendly research tools has increased dramatically in recent years, especially 
since the Copenhagen Climate Summit in 2009. In the extraction of bioactive 
compounds from chrysanthemum, modern extraction techniques such as 
pressurized fluid extraction (PFE), pressurized hot water extraction (PHWE) 
have become more popular than the conventional method such as steam 
distillation which is time-consuming (6-8 h of distillation) and sample-wasting 
(50-1000 g) (120, 127). They also benefit from their easy automation which 
makes them superior to ultrasonic extraction (USE) (128, 129).  Previously, 
most of the extractions of plants were carried out using organic or aqueous 
organic solvents (130-132) which were effective but threatening to the 
environment. Water can be described as a ―green‖ solvent, because it is 




nontoxic, nonflammable and it poses no threat to the environment. It is also 
readily available and cheap. Technically, water is attractive because its 
properties changes dramatically with temperature and pressure. Pressurized 
water at elevated temperature can be used in place of organic solvents in 
extraction (133). In PHWE, the applied temperature is generally the main 
parameter affecting extraction efficiency and selectivity. Pressure is usually 
applied to maintain water in the liquid phase, and its effect on the extraction 
efficiency is usually not significant (12, 134). However, the study on the use 
of PHWE with pattern recognition tools for the classification and quality 
control of botanicals has been limited.  
The aim of the current work is to develop an economical and effective quality 
control approach using green-solvent methods based on PHWE for the 
extraction of varieties of chrysanthemum combined with simple and high 
throughout HPLC-UV for detection. Under the optimum conditions, the 
extraction efficiency of PHWE is evaluated by comparing with vortex 
extraction and extraction by heating under reflux. For data analysis, Principal 
Component Analysis (PCA) is applied to study the classification and 
separation of different varieties of chrysanthemum according to uses, species, 
provenance and quality. To show that PHWE is practical and effective as a 
green method, methanol is employed as the alternative extraction solvent in 
the same operation system (i.e. PFE with methanol) for comparison. 
3.2 Materials and methods 
3.2.1 Chemicals and reagents  




All reagents were of HPLC grade. Methanol was the product of Tedia (US). 
Isopropyl alcohol was purchased from Fisher scientific (Loughborough, 
Leicestershire LE11 5RG UK). Formic acid was obtained from Fluka (Sigma-
Aldrich Pte Ltd, Science Park II, Singapore). Chlorogenic acid, luteolin and 
apigenin were purchased from Sigma-Aldrich (Sigma-Aldrich Pte Ltd, 
Science Park II, Singapore) Sand (white quartz, 50-70 mesh) was purchased 
from Sigma (St. Louis, MO, USA). Ultra-pure water was obtained using a 
Millipore Direct-Q UV ultrapure water system (Millipore S. A. S, Molsheim, 
France). Chrysanthemum flowers were purchased from local medical halls. 
3.2.2 Preparation of reference standards 
Stock solutions of chlorogenic acid, luteolin and apigenin at 100 ppm were 
prepared in methanol. For all analysis, the working solutions of chlorogenic 
acid, luteolin and apigenin were prepared in the range of 0.5 – 100 ppm in 
methanol and their linearity was determined. For the quantitation of marker 
compounds, a seven-point calibration based on the linearity established was 
used. 
3.2.3 Preparation of medicinal plants  
For the real samples used in this study, 13 samples classified as 3 groups 
based on the food-processing extent were used and the sample information 
was listed in Table 3.1. Amongst them, Sample 1-9 were Traditional Chinese 
Medicines (TCMs) which only need simple food processing procedures; 
Sample 10 and 11 were fresh chrysanthemum flowers which seldom need food 
processing; while Sample 12 and 13 were deep-processed food. In details, 




Sample 12 was packaged chrysanthemum herbal tea mixed with tea leaves and 
chrysanthemum leaves, and Sample 13 was packaged instant tea of 
chrysanthemum and ginseng extract which contained white chrysanthemum, 
ginseng, pearl powder, honey, sugar and others. To prepare a homogenous 
sample, the real sample of chrysanthemum was ground using an IKA MF10 
microfine grinder (Staufen, Germany) with sieve insert of hole size 0.5 mm. 
For PHWE/PFE, 1 g of the chrysanthemum sample was weighed directly into 
a glass tube and mixed thoroughly with a high proportion of sand. The sand 
and plant material mixture were transferred into the extraction cell for 
PHWE/PFE as mentioned below. The extraction cell was finally filled with 












Table 3. 1 Sample information of chrysanthemum samples used in the fingerprinting analysis by PFE/PHWE-HPLC/UV 
Group Sample 
No. 





1 White chrysanthemum Hang Zhou It is of medium quality.  
2 White chrysanthemum Hang Zhou It is of medium quality. Samples 1 and 2 are 
from different factories. 
3 White chrysanthemum Hang Zhou It is of high quality.  
 4 Chuju Chu Zhou in Anhui Province Samples 4 and 5 are from different factories. 
 5 Chuju Chu Zhou in Anhui Province  
 6 Tribute chrysanthemum Huang Shan in Anhui Province Samples 6 and 7 are from different factories. 
 7 Tribute chrysanthemum Huang Shan in Anhui Province  
 8 Boju Bo Zhou in Anhui Province  
 9 Wild chrysanthemum He Bei  
Fresh flower 10 Big chrysanthemum Japan  





12 Chrysanthemum Herbal Tea  Tai Wan It is a mixture of chrysanthemum flowers, tea 
leaves and chrysanthemum leaves. 
13 Instant tea of chrysanthemum and 
Ginseng Extract 
Singapore It contains white chrysanthemum, ginseng, 
pearl powder, honey, sugar etc. 





3.2.4.1 Vortex extraction 
Briefly, 0.02 g of ground chrysanthemum sample was extracted with 1 mL of 
solvent (methanol, water) at room temperature for 30 min and filtered. The 
extracts were then obtained. 
3.2.4.2 Extraction by heating under reflux 
Weigh 1 g chrysanthemum into a round bottom flask, then add in 50 mL 
solvent (methanol, water) and gently reflux the mixture at the boiling point for 
1h in an electromantle before centrifuging at 2000 rpm for 10 min to isolate 
the extract. 
3.2.4.3 Pressurized hot water extraction (PHWE)/Pressurized fluid 
extraction (PFE) system 
For the instrumentation used for PHWE/PFE, the stainless steel tubings were 
1/16 inch OD and 0.18 mm ID. The extraction cells from Phenomenex were 
made of stainless steel with 10 mm ID × 1/2 inch OD × 250 mm lengh (approx. 
17 ml). The extraction cell was heated in a HP5890, gas chromatograph oven 
(Hewlett Packard, USA). The pump used was a Shimadzu LC-10AT HPLC 
pump (Kyoto, Japan). The pump flow was set at 1.5 mL/min and the oven 
temperature from 60 °C to 140 °C was studied. The pressure in the system 
indicated by the HPLC pump was between 20 and 30 bar. The extraction cell 
was pre- filled with water (for PHWE) or methanol (for PFE) to check for 
possible leakage before setting the temperature of the oven to the required 




value. Extraction with water or methanol was carried out for a period of 30 
min and 45 - 50 ml of liquid was collected. In between runs, the system was 
washed with water or methanol for 5 min. The extracts were transferred into a 
50 ml volumetric flask. 
3.2.5 HPLC apparatus and operating conditions 
The HPLC system (Agilent Technologies 1200 Series, Agilent Technologies, 
Germany) consisted of a degasser, a quaternary pump, an autosampler, a UV 
detector and LC1200 software. A Waters XTerra® MS C18 column (5 μm, 
3.9×150 mm) was used for the separation of chlorogenic acid, luteolin, 
apigenin and the chrysanthemum extracts. The tested samples were separated 
at 25 °C with a gradient elution program at the flow rate of 0.7 mL/min. The 
mobile phase was a mixture of H2O in 0.1% formic acid (solvent A) and 
MeOH in 0.1% formic acid (solvent B). The gradient elution program was: 5-
50% B (0-5 min), 50% B (5-20 min), 5% B (20-30 min). The UV spectra were 
recorded at 310 nm and the injection volume of each sample was 10 μL. 
3.2.6 Data processing using Principal Component Analysis (PCA) 
For processing of HPLC-UV fingerprint data, each sample was represented by 
a chromatogram. With the detected peaks, a multi-dimensional vector was 
constructed manually to characterize the b iochemical patterns. Each vector 
was normalized to the total sum of vector intensity as this is to account for 
concentration difference due to the different sample size used. Identities of 
HPLC-UV detected peaks were established based on the reference standards. 
The resulting data comprising of retention times and peak heights were then 




exported to Simca-P+ Software Package (Umetrics, Umea, Sweden). Data 
mining tools such as Principal Component Analysis (PCA) enable the 
translation of peak heights into principal components (PCs) where there are 
scores describing different chromatograms obtained. The distribution patterns 
generated from the data can be correlated to general characteristics of the 
samples analyzed. It also enables the evaluation of similarities and differences 
in the chromatograms. 
3.3 Results and discussions 
3.3.1 Confirmation of the HPLC-UV method 
The RSD values (n=6) of 1.93, 1.84 and 1.80% were obtained for chlorogenic 
acid, luteolin and apigenin at the concentration level of 100 ppm, respectively. 
The working solutions of these three compounds were prepared in the range of 
0.5-100 ppm in methanol and their linearity was determined to be good as the 
correlation coefficients were more than 0.9999. The satisfactory precision and 
linearity of the HPLC method could ensure the reliable evaluation of PHWE 
and the establishment of the chromatographic profile in subsequent studies. 
3.3.2 Optimization and evaluation of PHWE/PFE 
The main parameters that affected the extraction efficiency of PHWE were 
temperature, pressure, extraction time and flow rate (5). Pressure had little 
effect on the extraction efficiency but was generally kept high enough to 
maintain the extraction solvent in liquid phase at the elevated applied 
temperature (134). The time for extraction was set at 30 min as previous 




studies had shown that a significant amount of target analytes would be 
extracted in the first 30 min (14, 135). The key parameter that would have a 
significant effect on the extraction efficiency of PHWE was the extraction 
temperature (13, 112, 136). Hence, the effect of temperature on the extraction 
efficiency of chlorogenic acid, luteolin and apiginin was studied within the 
range of 60 to 140 °C. Figure 3.1 (A1, B1 and C1) shows the effect of 
temperature on the amounts of chlorogenic acid (A1), luteolin (B1) and 
apigenin (C1) extracted from chrysanthemum by PHWE. On the whole, more 
of the target compounds could be extracted with increasing temperature. 
Hence 140 °C was selected as the optimal temperature of PHWE.  
To evaluate the extraction efficiency of plant extraction by PHWE, 
comparison with other methods such as Soxhlet extraction and extraction by 
heating under reflux was done (14, 116). The use of standards, if recovery 
analysis was performed, could be avoided due to the minimization of intrinsic 
plant matrix effects by this comparison method. Hence in this study, the 
relative effectiveness of extraction of PHWE at 140 °C for chlorogenic acid, 
luteolin and apigenin was compared with vortex extraction and extraction by 
heating under reflux and the results obtained are shown in Figure 3.1 (D1, E1 
and F1). Higher amounts of chlorogenic acid and luteolin were obtained by 
PHWE compared with the two other extraction methods. While for apigenin, 
the amount extracted by PHWE was relatively lower than that of vortex 
extraction, but higher than that obtained by heating under reflux. As apigenin 
was a thermally unstable compound (137), it was reasonable that the most 
effective method was vortex extraction which was carried out at room 




temperature. However, of the two extraction methods which involved heating, 
PHWE was found to extract higher amount of apigenin than heating under 
reflux. In summary, PHWE could be an effective method for the extraction of 
bioactive compounds from botanical food and herbal medicines, specifically 
from chrysanthemum in this case. The more effective extraction by PHWE is 
attributed to a combination of both enhanced solubility, and dynamic supply of 
fresh water to wet and penetrate the plant matrix deeper at elevated 
temperature. This disrupted the solute-matrix interaction more than the 
conventional methods with a fixed volume of water. The  analytes extracted 
with PHWE could then be brought to the surface of the matrix and 
subsequently eluted out of the extraction cell (6, 125). 
In this study, PFE with MeOH was also investigated with the same procedure 
before the chromatographic fingerprinting analysis. Figure 3.1 (A2, B2 and C2) 
shows the effect of temperature on the amount of chlorogenic acid (A2), 
luteolin (B2) and apigenin (C2) extracted from chrysanthemum by PFE using 
MeOH as extraction solvent. It was observed that by increasing the 
temperature, more of each compound could be extracted. However, in the case 
of chlorogenic acid (A2) and apigenin (C2), increasing the temperature further 
only resulted in a decrease in the amount extracted beyond 100 °C and 80 °C, 
respectively. Taking all the three compounds into consideration, 100 °C was 
selected as the optimal temperature of PFE with MeOH. Subsequently, the 
extraction efficiency of PFE with MeOH at 100 °C for chlorogenic acid, 
luteolin and apigenin was compared with vortex extraction and extraction by 
heating under reflux and the results obtained are shown in Figure 3.1 (D2, E2 




and F2). For PFE of chlorogenic acid and luteolin, their extraction efficiencies 
were significantly higher than those obtained with vortex extraction and 
heating under reflux, while for PFE of apigenin, the extraction efficiency 
obtained using PFE was comparable with that of the other two methods.  
 
 


















Figure 3. 1 Effect of temperature on the amount of (A1) Chlorogenic acid, (B1) Luteolin and (C1) Apigenin extracted from 
chrysanthemum by PHWE; comparison of amount of (D1) chlorogenic acid, (E1) luteolin and (F1) apigenin extracted from 
chrysanthemum by PHWE (140°C) with vortex and heating under reflux. Effect of temperature on the amount of (A2) 
Chlorogenic acid, (B2) Luteolin and (C2) Apigenin from chrysanthemum by PFE; comparison of amount of (D2) chlorogenic 
acid, (E2) luteolin and (F2) apigenin extracted from chrysanthemum by PHWE (100°C) with vortex and heating under reflux. 
Other PHWE/PFE conditions: flow rate, 1.5 mL/min; time for extraction, 30 min. 




3.3.3 Chemical fingerprints with PCA 
The HPLC analyses were then carried out with the extracts obtained from the 
abovementioned two extraction systems. In Figure 3.2, the typical HPLC 
chromatographic profiles of PHWE extracts (A1, B1, C1) and PFE extracts 
(A2, B2, C2) are shown respectively. Sample 1 (A1, A2) in TCM group, 
Sample 11 (B1, B2) in fresh flower group and Sample 12 (C1, C2) in the 
deep-processed packaged tea bag group were used. It could be seen that 
chromatograms of different chrysanthemum samples varied a lot, and 
chromatograms of the same sample obtained using different extraction 
solvents also showed differences. In order to evaluate the extent of the 
differences or similarities, the statistical tool PCA was utilized. In a typical 
PCA analysis in our study, the SIMCA P+ software was used to calculate the 
parameters which allowed dimensional reduction while sacrificing as little 
accuracy as possible. From the PCA analysis, several hundred of variables 
(chromatographic peaks) representing one chromatogram could be reduced to 
two variables, which could be demonstrated as a single point in a two-
dimensional plot (represented as individual sample points in Figure 3.3 and 
Figure 3.4). Sample points that clustered together would have more similar 
spectra. Figure 3.3 and Figure 3.4 are two-dimensional plots, and hence 2 
components are used in each plot. The PCA score plots obtained after PFE 
with MeOH (Figure 3.3A) and PHWE with water (Figure 3.3B) show that the 
9 samples in the TCM group cluster together and separate well away from the 
fresh flowers group and the packaged tea bag group. The TCM specific group 
separation was not only a very interesting result, but it also underlines that this 




feature is clearly dominant over the other features (namely, variety and origin). 
In Figure 3.3, it also demonstrates the contribution plots of chrysanthemum 
samples in TCM group by PFE with MeOH (Figure 3.3C) and PHWE (Figure 
3.3D) over the samples in the other 2 groups. In both figures, a number of 
components contribute to the classification of TCM over the others, including 
chlorogenic acid, luteolin and apiginin. Especially for chlorogenic acid, an 
antioxidant that has been used as a food active ingredient, it plays quite an 
important role for the classification of TCM chrysanthemum against the fresh 
flowers and deep-processed products as it is almost the highest component in 
Figure 3.3C and D. 
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Figure 3. 2 Chromatographic profile of PHWE extracts (A1, B1, C1) and PFE extracts (A2, B2, C2). Sample information: A1 and 
A2 are White Chrysanthemums (Sample 1 listed in Table 3.1); B1 and B2 are fresh chrysanthemum flowers (Sample 11 listed in 
Table 3.1); C1 and C2 are packaged tea bags of chrysanthemum herbal tea (Sample 12 listed in Table 3.1). 

























































































































































































































































































































































































































































Figure 3. 3 PCA score plots of 13 chrysanthemum samples by (A) PFE with MeOH (R2X[1]=0.288676, R2X[2]=0.225366) and 
(B) PHWE (R2X[1]= 0.323383, R2X[2]= 0.178500). Red triangle: TCM group, green dot: ornamental group, blue box: packaged 
tea bag group; contribution plots of chrysanthemum samples by (C) PFE with MeOH and (D) PHWE in TCM group over the 
samples in ornamental group and packaged tea bag group, Chl: chlorogenic acid, Lut: luteolin, Api: apiginin.  




A consequence of this observation was that separation of additional features 
required higher sample homogeneity, so the following analysis was restricted 
only to the TCM group. There are 4 varieties of chrysanthemum tea in China 
which are very well-known, namely, White chrysanthemum of Hangzhou, 
Tribute chrysanthemum of Huangshan, Boju of Bozhou, as well as Chuju of 
Chuzhou. Amongst them, Tribute chrysanthemum, Boju and Chuju all 
originate from Anhui Province. Besides that, wild chrysanthemum is also a 
very important source of TCM. To discriminate other attributes from fresh 
flowers and packaged tea, we restricted our second analysis to 9 TCM samples 
including the above mentioned 5 species of chrysanthemum. PFE with MeOH 
and PHWE were carried out followed by PCA, and the results are shown in 
Figure 3.4. PCA examination of the metabolic profiles demonstrates striking 
differences between the 5 species in both PFE extracts and PHWE extracts. 
This result confirms our hypothesis that by removing samples in the 
ornamental group and the packaged tea group, we could decrease variability 
between samples and thereby improving separation of other more subtle 
features like TCM species or provenance (138). 
The PHWE/PFE of each chrysanthemum sample was carried out three times in 
order to study their precision and the separation efficiency on PCA. Although 
the 5 species of chrysanthemum  could be clearly separated for the MeOH 
extracts, the three types of White Chrysanthemum samples were not 
differentiated (as indicated by the yellow eclipse in Figure 3.4A). By using 
water as the extracting solvent in PHWE, the three White Chrysanthemum 
samples that were previously not possible to differentiate by PFE using 




methanol could then be resolved clearly from one another (Figure 3.4B as 
indicated within the yellow eclipse). Moreover, it was also possible to 
discriminate Sample 3 (red box symbols) which is of higher quality from 
Samples 1 and 2 (red triangles and red dots, respectively) which were of 
medium quality only. In addition, Tribute chrysanthemum, Boju and Chuju 
were observed to cluster in the same region, whose provenances were in the 
same district of China, Anhui Province (as indicated by the green eclipses in 
Figure 3.4B). The similar natural conditions including soil and climate led to 
quality similarity (139). All in all, PHWE-HPLC/UV analysis coupled with 
PCA provided an excellent prediction and separation tool. The results also 
suggest that PHWE allows the generation of ample and appropriate 
information for use with PCA for the efficient separation and/or classification 
of different chrysanthemum features like species and provenance. The use of 
water as extracting solvent produced results that were in some ways superior 
as compared to that of MeOH. Firstly, water is an environmentally more 
benign solvent compared with methanol. Furthermore, under subcritical 
conditions, the relative permittivity of water can be reduced gradually by 
simply increasing the temperature at constant pressure (1, 119). This results in 
water possessing properties that enabled the solubilization of components of a 
wider range of polarity. Better differentiated results were then possible as 
these components might provide information which was able to better 
represent the sample. This was probably the reason why PHWE resulted in 
better classification of different Chrysanthemum features as observed in this 




study. Hence, the use of water as a green solvent has its pract icality and 
advantages. 
 
Figure 3. 4 PCA score plots of 9 chrysanthemum samples of TCM group by 
(A) PFE with MeOH (R2X[1]=0.328194, R2X[2]=0.227471) and (B) PHWE 
(R2X[1]=0.321004, R2X[2]=0.251105). Red: White chrysanthemum (triangle: 
Sample 1 of medium quality, dot: Sample 2 of medium quality, box: Sample 3 
of high quality), green: Chuju, blue: Tribute chrysanthemum, orange: Boju, 
purple: Wild chrysanthemum. The symbols with the same shape and color 
represented the same sample as 3 parallel extractions and analysis were carried 
out for each sample. 
 




3.4 Concluding remarks 
Our work indicates that PHWE was capable of effective extraction of 
bioactive compounds from chrysanthemum with water as extraction solvents, 
which is non-toxic and economical. Based on the comparison with the extracts 
obtained from PFE with MeOH, it was found that better separation and 
classification could be observed in the PCA score plots obtained using the 
extracts from PHWE with water. Under the optimized PHWE conditions, 
establishment of chrysanthemum profiles by HPLC-UV, and data processing 
by unsupervised multivariate procedures based on PCA allowed for the 
digitalization of chrysanthemum properties providing a novel approach for 
objective annotation of different chrysanthemum attributes such as species, 
provenance and quality. Thus our study has offered an economical, effective 










METABOLOMIC AND METALLOMIC STUDIES 




Chapter 4 Metabolomic analysis of tissue and serum from 
hypercholesterolemic rats injected with berberine using 
1
H 
NMR and GC-MS 
4.1 Introduction 
Metabolomics is defined as the quantitative measurement of the dynamic 
multiparametric metabolic response to pathophysiological stimuli or genetic 
modifications (140). The use of metabolic profiling provides new insight into 
pathogenesis of disease and an understanding of individual patient’s 
susceptibility to treatment and adverse events that will bring us closer to 
personalized medicine (141, 142).  High resolution nuclear magnetic 
resonance (NMR) approaches have been used extensively for metabolic 
profiling of mouse or rat urine and tissue samples for the monitoring of diet 
effects, evaluation of toxicity of chemical substances and fingerprinting of 
markers of human intracranial tuberculomas (143-147). Gas chromatography 
mass spectrometry (GC-MS) with multivariate statistical tools is commonly 
used to compare metabolic signatures in various biological samples (146, 148-
150).  
In pre-clinical settings, metabolic profiling can offer information that is robust 
and reproducible rapidly for existing studies of drug metabolism and efficacy. 
Tissue and blood serum biomarkers may be appropriate for per-clinical 
screening of chemical substances (141). Since each analytical technique has its 
own unique advantages and drawbacks, we propose to use multiple analytical 
techniques for metabolic profiling. It is apparent that a multi-analytical 




approach, capitalizing on the complementary nature of 1H NMR, GC-MS and 
LC-MS, is likely to produce a more comprehensive metabolic profile than just 
deploying a single technique (146, 148, 150). Based on other reports and our 
earlier works, it was observed that additional information could be obtained 
using a combination of 1H NMR and GC-MS for the profiling of metabolites 
in different biological samples (148, 151, 152). For the analysis of complex 
metabolic profiles, pattern recognition tools such as principal component 
analysis (PCA) are commonly used to establish any related clustering that may 
exist in a data set (143-151).  
Berberine, an isoquinoline alkaloid of the protoberberine type, is derived from 
the root, rhizome, and stem bark of many plant species and is commonly used 
in traditional Chinese medicine. It is reported to have multiple 
pharmacological properties such as anti-diabetic (153, 154), anti-microbial 
(155), anti- inflammatory (156), anti-cancer (157) and others. In addition, 
berberine is reported to be a cholesterol lowering drug working through a 
unique mechanism distinct from statins (158). A combination of simvastatin 
with berberine was reported to improve the lipid- lowering efficacy in rats and 
hypercholesterolemic patients (159). Moreover, the co-administration of 
berberine with plant sterols synergistically was able to lower plasma 
cholesterol levels and significantly reduce liver cholesterol in male Sprague 
Dawley rats fed with a high-fat and high-cholesterol (HFHC) diet without any 
toxic effects (160). In most of the scientific reports, the effect of berberine on 
a hypercholesterolemic animal model was studied through the investigation of 
some particular biomarkers, including total cholesterol (161), cardiac fatty 




acid transport protein-1 (162) and hepatic genes involved in glucose and lipd 
metabolism (163), etc. It was only recently that the metabolomic study on the 
therapeutic effects of the crude drug devived from Coptis chinensis was 
reported. In this study, metabolomics was proved to be a valid approach for 
explaining the therapeutic effects of herbal medicines although a single 
platform LC-MS was employed (164). 
In this study, we report the effect of berberine at a dosage of 50 mg/kg on the 
serum and liver cholesterol from male Sprague Dawley rats fed with a high fat 
and high-cholesterol (HFHC) diet. In addition, the current approach based on 
GC-MS and 1H NMR is used to study the metabolic profiles in the liver, 
serum, heart and kidney samples associated with the weight lost and 
cholesterol lowering effects of berberine in the livers of Sprague Dawley rats. 
Finally, a set of appropriate biomarkers associated with the metabolism of 
berberine in the tissue samples collected will be identified.  
4.2 Materials and methods 
4.2.1 Chemicals 
Pure deionised water was obtained from Millipore Alpha-Q water system 
(Bedford, MA, USA). Chloroform (CHCl3), pyridine and stearic acid were 
purchased from Merck (Darmstadt, Germany). N,O-bis(trimethylsilyl)-
triﬂuoroacetamide (BSTFA), berberine, cholesterol, myristic acid, palmitic 
acid, deuterated water (D2O, containing 0.03wt% 3-(trimethylsilyl)propionic-
acid, sodium salt, TSP) and deuterochloroform (CDCl3, containing 0.03% 
tetramethylsilane, (CH3)4Si, TMS) were purchased from Sigma-Aldrich 




(St.Louis, MO, USA). Glucose, galactose, fructose, mannose, maltose, ribose, 
xylose, alanine, glycerol and glycine were purchased from Fluka BioChemika 
(Switzerland). HPLC grade methanol was purchased from Tedia (Fairﬁeld, 
OH, USA). 
4.2.2 Animal studies 
Male rats (Sprague Dawley) were purchased from Laboratory Animals Centre, 
National University of Singapore (NUS). All of the animal experiment 
protocols used in this experiment complied with the institutional guidelines of 
NUS Institutional Animal Care and Use Committee (IACUC). The animals 
were acclimatized in standard rodent cages with individual ventilation. The 
animal room was maintained at 25  2oC with natural day/night cycle. Food 
and water were provided ad libitum. High-fat and high-cholesterol (HFHC) 
diet, containing 2% cholesterol, 5% fat and 18% protein in pellet form (Harlan 
Teklad, USA), was provided to all rats during the course of the experiment. 
Following a 28 day acclimatization period, animals were randomly allocated 
into 2 groups comprising 8 animals in control group and 6 in treated group. 
The treated group was administrated with berberine at a dose of 50 mg/kg 
while the control group received saline, both via intraperitoneal (IP) injection 
at 0 and 48 hours. All animals were housed individually in metabolism cages 
for the ease of urine collection. Body weights of individual rats were measured 
at the beginning of the experiment, weekly and at the time of sacrifice. All 
animals were sacrificed at the end of the experiment via carbon dioxide 
asphyxiation. Post mortem examination was done on all animals. The livers, 




kidneys and hearts of each rat from the control and treated groups were 
preserved in 10% buffered formalin solution for histopathological examination. 
In addition, blood samples collected from all rats underwent immediate 
centrifugation to obtain serum samples. Due to unexpected contamination, 
only the data obtained from six out of the eight rats from the treated group 
were considered in this study. 
4.2.3 Sample Preparation for GC-MS 
The tissue samples, including livers, kidneys and hearts, were extracted using 
a method adapted from an earlier report (165). Briefly, 50 mg of the individual 
tissues were dried using liquid nitrogen and extracted with 0.5mL of CHCl3 : 
CH3OH (3:1). After centrifugation at 161 000 × g for 5 min, the supernatant 
was lyophilized. Dried sample extracts (lipid fraction) were reconstituted in 
100 L pyridine. 50 L of BSTFA was added to each dried sample extract for 
derivatization for 120 minutes each. The resulting solution underwent 
agitation for 1 minute under room temperature and transferred to an amber vial 
for GC-MS analysis.  
For the serum samples, 100 L of MeOH was added to 100 L of serum 
sample, followed by centrifugation at 161 000 × g for 5 min. The supernatant 
was lyophilized and then reconstituted in 100 L pyridine. 50 L of BSTFA 
was added in for derivatization for 120 minutes. The resulting mixture 
underwent vortex for 1 minute under room temperature and was transferred to 
an amber vial for GC-MS analysis. 
 




4.2.4 Sample Preparation for 1H NMR 
For 1H NMR analysis, the lipid fraction of the tissue extracts were prepared by 
drying individual tissues using liquid nitrogen followed by extraction using 
0.5mL of CHCl3 : CH3OH (3:1). After centrifugation at 161 000 × g for 5 min, 
the supernatant was lyophilized. The aqueous fraction was obtained by 
extracting the dried tissue samples using 0.5mL of CH3OH : H2O (1:1). The 
lipid extracts of the tissues were reconstituted in 650 L of CDCl3 containing 
0.03% TMS while the aqueous extracts were reconstituted in 600 L 
phosphate buffered D2O containing 0.05% TSP. Serum samples were prepared 
by adding 200L of serum sample to 400L of saline solution (0.9% [w/v] 
NaCl in D2O) containing 0.05% TSP. The solutions were then pipetted into 
individual NMR tubes (5mm O.D, 7 inch length, Sigma-Aldrich) for NMR 
analysis. 
4.2.5 Analysis of tissue and serum samples using GC-MS 
1.0 L aliquot of the BSTFA-derivatized sample with standard was injected 
using the splitless mode with a Shimadzu AOC-5000 series auto injector into a 
Shimadzu GC-2010 GC system equipped with a Shimadzu DB5-MS capillary 
column (30.0 m x 0.25 mm ID x 0.25 m). The inlet temperature was set at 
250oC. Helium was used as the carrier gas with a constant flow rate of 1.40 
mL/min through the column. The initial temperature was set at 100oC, 1 
minute after injection the GC temperature was increased at a rate of 5oC/min 
to 280oC and held for 5 minutes at 300oC. The transfer line temperature was 
set at 280oC. Detection was achieved using MS in electron impact mode and 




full scan monitoring (m/z 100 to 600). The temperature of the ion source was 
set at 250oC. 
4.2.6 Analysis of tissue and serum samples using 1H NMR 
One dimensional 1H NMR spectra for the tissue extract and serum samples 
were obtained on a Bruker DRX500 operating at 500.15 MHz observation 
frequency and equipped with TXI cryoprobe. Aqueous tissue extracts were 
analyzed with standard 1D pulse sequence with zgpr as a presaturation 
sequence for water suppression. Typically, 64 scans were collected with 32K 
data points over a spectra width of 7003Hz and an acquisition time of 2.3s. 
Lipid tissue extracts were also analyzed using a single 90o pulse, but with no 
solvent suppression. This was done by having 64 scans collected with 32K 
data points over a spectra width of 7508Hz and an acquisition time of 2.2s. 
Serum samples were analyzed with standard Carr-Purcell-Meiboom-Gill 
(CPMG) spin-echo pulse sequence, for emphasis of resonances of low 
molecular weight metabolites (166), in addition to the water suppression pulse 
sequence. A total of 64 scans were collected, with 32K data points over a 
spectra width of 5482Hz and an acquisition time of 3s. Spectra were 
referenced to an internal reference standard TSP dissolved in D2O for the 
aqueous tissue extracts and serum samples, and TMS in CDCl3 for the lipid 
fractions of tissue extracts to provide a field-frequency lock. 
4.2.7 Chemometric analysis 
For GC-MS, each sample was represented by a GC-MS total ion 
chromatogram (TIC). The data was exported to GCMS Solutions (Shimadzu, 




Kyoto, Japan) for the determination of perturbed metabolites. Among the 
detected peaks, a multi-dimensional vector was constructed to characterize the 
biochemical pattern. Each vector was normalized to the total sum of vector 
intensity, thereby partially accounting for variation in concentrations due to 
the different sample sizes used. Peaks due to column bleed and derivatizing 
reagent were removed. The identification of peaks was based on the use of 
reference standards and NIST library. The mass spectra obtained were 
inspected manually and only those molecules with probability matching higher 
than 90% were considered. 
Fourier transformed 1H NMR spectra were manually phased and baseline 
corrected using the 1DWINNMR software (Bruker Biospin). Each spectrum 
was integrated between 0.5 to 4.5 and 5.1 to 10 ppm. The spectral region 
containing the water resonance was removed from all data sets prior to 
normalization and multivariate data analysis in order to eliminate variation due 
to suppression efficiency. The resulting two-dimensional data, 1H chemical 
shift, and peak heights were generated.  
All data exported from 1H NMR and GC-MS were normalized to account for 
any differences inherent in samples. The normalization step is crucial prior to 
further data analysis because it can greatly influence outliers and overall 
dataset projection by a chosen algorithm. 
From the normalized data obtained from GC-MS and 1H NMR, indication of 
significance was based on a two-tailed student t-test performed with Microsoft 
Excel software (Microsoft Corporation, USA). For the identification of 




potential biomarkers, two-tailed student t-test (p < 0.05, p<0.01 and p<0.001) 
was used. 
The resulting normalized GC-MS and 1H NMR data were then exported to 
Simca-P+ Software package (Umetrics, Umea, Sweden) for subsequent 
processing by unsupervised method.  For PCA, the data were reduced to two 
latent variables (or principal components, PCs) that would describe maximum 
variation within the data. The PCs which were obtained from the scores would 
highlight clustering, trends and outliers in the observation direction of data set. 
4.3 Results and discussion 
4.3.1 Analysis of metabolites in rat tissue and serum samples by GC-MS 
The dose of berberine at 50 mg/kg used in the current work was based on 
other reports (154, 158-160). From Figure 4.1, a decrease in whole body 
weight for rats administrated with berberine was observed, which was 
consistent with other report (167). 




























Plot of Rat Weight against Days
 
Figure 4. 1 Body weight changes characteristic of the hypercholesterolemic 
rats. The results are shown by their average weight with standard deviation 
(Control group: Red  (n=8), Treated Group: Green  (n=6)). 
 
Following extraction and derivatization, as described in the experimental 
section, the tissue samples were subjected to analysis by capillary GC-MS 
using electron impact (EI) techniques. Visual examination of the traces 
revealed numerous peaks that were relatively lower or higher in the serum 
samples and tissue extracts between the two groups (Figure S4.1, Appendix 1). 
PCA of these data showed that the samples from the two groups gave clusters 
that were readily separated from each other (Figure 4.2). The QC samples 
(data not shown), that were used to monitor the overall analytical procedure, 
clustered closely together providing confidence in the reproducibility of the 
extraction, derivatization and chromatographic procedures. Metabolites from 




the serum and tissue samples that were observed to be significantly different 
(based on a two-tailed Student’s t-test) for the two groups were summarized in 
Tables S4.1 to S4.4 (Appendix 1). Our data showed that the levels of 
cholesterol and glucose were not significantly reduced in the serum, liver, 
heart and kidney samples collected. However, changes in a number of sugars 
and fatty acids were observed in the tissue samples analyzed (Tables S4.1-









Figure 4. 2 PCA score plots based on GC-MS analysis of hypercholesterolemic rats (A) Liver {R2X[1]=0.252, R2X[2]=0.213}, 
(B) Serum {R2X[1]=0.379, R2X[2]=0.192}, (C) Heart {R2X[1]=0.226, R2X[2]=0.199} and (D) Kidney {R2X[1]=0.284, 
R2X[2]=0.159} samples from the control (n=8) and treated group (n=6). (Red  : Control group, Green : Treated group, all the 
tissue samples were in lipid fractions).  




4.3.2 Analysis of metabolites in rat tissue and serum samples by 1H NMR 
Typical 1H NMR spectra of the control and berberine treated group’s tissue 
and serum samples in aqueous fraction acquired using the standard 1D pulse 
sequence for water suppression were shown in Figure S4.2a and S4.2b 
(Appendix 1). The PCA score plot showed clusters for data obtained from the 
two groups (Figure 4.3). Finally, a two-tailed Student’s t-test (p < 0.05 and p< 
0.01) was used to identify metabolites that were expected to be perturbed 
between the two groups (Tables S4.5-S4.8) (Appendix 1). Despite not 
observing changes of some common metabolites in liver and heart samples, 
there were changes in a number of metabolites such as amino acids in the 


























Figure 4. 3 PCA score plots based on 1H NMR analysis of hypercholesterolemic rats of aqueous fractions (A) Liver 
{R2X[1]=0.259, R2X[2]=0.159}, (B) Serum {R2X[1]=0.310, R2X[2]=0.173}, (C) Heart {R2X[1]=0.691, R2X[2]=0.109} and (D) 
Kidney {R2X[1]=0.460, R2X[2]=0.167} samples from the control (n=8) and treated group (n=6). (Red  : Control group, Green : 
Treated group) 




Table 4. 1 Summary of key metabolites that were identified in tissue and serum samples obtained from hypercholesteromlemic 
rats with berberine administration (50 mg/kg).  
 Metabolites found in 
liver 
Metabolites found in 
Serum 
Metabolites found in 
Heart 






























































† Reduction in the level of cholesterol was observed in the liver samples as measured by 1H NMR and GC-MS. 
* Level of metabolites that were found to be decreased and increased is based on statistical analysis as in Table S1-S11. The statistics are as follows: 
significance difference between the control group (n=8) and treated group (n=6) is based on two tailed student t test (* p<0.05, ** p<0.01, ***p<0.001). 
Blue * labeled compounds resulted from GC-MS, while black * labeled compounds resulted from 1H NMR. Level of metabolites that were found to be 
unchanged resulted from 1H NMR and GC-MS. 




For the lipid fraction, 1H NMR spectra for the two groups are presented in 
Figure S4.3 (Appendix 1). A list of metabolites that were observed to be 
perturbed between the two groups was tabulated in Tables S4.9-S4.11 
(Appendix 1). However, the PCA score plot shows poor separation of clusters 
between the two groups (Figure 4.4). Although change in level of cholesterol 
was not significant, increases in levels of cholesterol esters (Tables S4.1, S4.3, 
S4.9, S4.10 in Appendix 1) were observed in the lipid faction for the tissue 
samples obtained from the heart and liver.   
Although normalization of total signal is a common practice, metabolomic 
data must be interpreted with caution since any change is in relation to the 
total spectral integration, rather than its absolute value. With the use of 
different analytical techniques, it is even more so that the same metabolites 
detected are required to normalize to a different constant sum. These can be 
seen in the present case for cholesterol when using 1H NMR and GC-MS 
(Table 4.1). Further, the close agreement of values obtained for cholesterol 
and glucose using different techniques shows that 1H NMR has good 
specificity for certain metabolites, and also the reliability of the current 
method of normalization. The current observation was consistent with our 
early works with human urine samples and tissues samples (151, 152).  
Although changes in the level of cholesterol in the liver samples was not 
statistically significant, the data obtained from GC-MS and 1H NMR indicated 
that the administration of berberine at 50 mg/kg resulted in a reduction of 
cholesterol in the rat liver samples collected. These observations further 




confirm that using a mult iple analytical approach does not just provide 
additional information, but also enhances the confidence of the data obtained.  





Figure 4. 4 PCA score plot based on 1H NMR analysis of 
hypercholesterolemic rat samples of the lipid fractions from the co ntrol (n=8) 
and treated group (n=6). (Red  : Control group, Green  : Treated group). (A) 
Liver (R2X[1]=0.358, R2X[2]=0.170),  (B) Heart (R2X[1]=0.273, 
R2X[2]=0.150) and (C) Kidney (R2X[1]=0.261, R2X[2]=0.182).  
 





In industrialized societies, atherosclerotic cardiovascular disease is the leading 
cause of morbidity and mortality. Berberine is a cholesterol- lowering drug 
acting through the stabilization of the low-density lipoprotein receptor 
messenger RNA (158-160). Treatment of hyperlipidemic animals such as 
hamsters with berberine by oral administration for 10 days resulted in dose 
dependent decreases in serum total cholesterol and low-density lipoprotein 
cholesterol (158). In addition, berberine is able to lower the glucose and 
cholesterol in livers of male Sprague Dawley rats fed with a normal diet. 
However, for male Sprague Dawley rats fed a cornstarch-casein-sucrose-based 
high-cholesterol (2%, w:w) and high-fat (27.5%) diet, the administration of 
berberine was observed to have no effect on the plasma total cholesterol (160).  
Cholesterol is an essential structural component of mammalian cell 
membranes; and cholesterol esters which are the major storage and transport 
forms can be inter-converted to cholesterol with several enzymes (168-170). 
The administration of berberine resulted in no change in the level of 
cholesterol in the heart, serum and kidney samples collected based on both 
GC-MS and 1H NMR results. However, a reduction in the hepatic level of 
cholesterol from the treated group was observed. The current observation that 
there is no change in the level of cholesterol in serum with a decrease in liver 
samples is consistent with that of a previous report (167). It is noted that the 
administration of berberine resulted in a shift in the inter-conversion of 
cholesterol and cholesterol esters in the rat liver. In addition, it changes the 
distribution of cholesterol esters without affecting the level of cholesterol in 




the heart samples. Hence, the administration of berberine was suggested to 
modify the hepatic cholesterol biosynthesis and distribution of cholesterol 
esters.   
Together with cholesterol, fatty acids can exist in its free form and are found 
as fatty acyl esters in complex molecules such as triacylglycerol. Lipoprotein 
lipase hydrolyses the triglyceride of chylomicrons, which will become the 
smaller cholesterol- rich chylomicron remnants. At the same time, fatty acids 
and monoglycerides released can be taken up locally by adipocytes or 
myocytes or by the liver. Free fatty acids can be oxidized by the liver to 
provide energy (170). An increase in fatty acid accumulation and cholesterol 
synthesis was observed in liver samples obtained from PPAR- null mouse 
(148). At the same time, a decrease in polyunsaturated fatty acids and an 
increase in mono-unsaturated fatty acids were observed in mouse livers as a 
result of drug induced hepatotoxicity (143-145). It is suggested that the 
reduction of hepatic cholesterol resulted in an elevation of free fatty acids to 
provide alternative energy for the metabolism of berberine and weight lost in 
treated group (Table 4.1).  Hence, it is proposed that the administration of 
berberine changes the metabolism of fatty acids in the liver, heart and kidney 
of the rats in the treated group.  
Glucose is a primary source of energy for living organisms and is synthesized 
in the liver and kidneys from non-carbohydrate intermediates, such as 
pyruvate and glycerol by a process known as gluconeogenesis. In another 
process known as glycogenolysis, animal glucose arises from the breakdown 




of glycogen. For male Sprague-Dawley rats fed with a high cholesterol and fat 
diet, the administration of berberine did not result in a change in the level of 
glucose in the various organs analyzed. However, the reduction of cholesterol 
in the rat liver (Table 4.1) and weight loss observed in the treated group 
(Figure 4.1) was found to affect myo-inositol which is a cyclic polyalcohol 
that plays an important role as a second messenger in a cell, in the form of 
inositol phosphates. Together with myo-inositol, D-ribose which is vital for 
life as a component of DNA, RNA, ATP, ADP, and AMP is affected. Ribose 
helps restore the level of adenine nucleotides by bypassing the rate- limiting 
step in the de novo (oxidative pentose phosphate) pathway, which regenerates 
5-phosphoribosyl- l-pyrophosphate (PRPP), the essential precursor for ATP 
(171). Hence, a shift in alternative carbohydrate metabolism is suggested for 
the reduction of cholesterol in the rat liver and weight loss observed in the 
treated group.  
Metabolic profiles of rat liver and kidney associated with metabolism of 
berberine and drug induced hepatotoxicity and nephrotoxicity can be rather 
different (144, 167). One of the prominent features in the current work is that 
the administration of berberine changes amino acids such as alanine, tyrosine, 
tryptophan, valine and leucine/isoleucine, in the rat kidney samples collected 
(Table 4.1). Amino acids are not only cell signaling molecules but also 
regulators of gene expression and the protein phosphorylation cascades. In 
addition, amino acids are key precursors for synthesis of hormones and low 
molecular weight nitrogenous substances that have enormous biological 
importance. Other than their roles as building blocks for proteins and peptides, 




some amino acids regulate key metabolic pathways that are necessary for 
maintenance, growth, reproduction and immunity (172). Hence, it is clear that 
the administration of berberine in the current study also resulted in a shift in 
transamination and amino acid biosynthesis in the rat kidney without affecting 
other organs. 
4.4 Concluding remarks 
The use of both 1H NMR and GC-MS with pattern recognition tools provided 
a comprehensive picture of metabolic changes in the tissue samples between 
the two groups. The current approach was robust and reproducible which did 
not require additional resources to existing in-vivo studies. A set of 
biomarkers in the liver, serum, heart and kidney samples associated with the 
weight lost and cholesterol lowering effects of berberine in the livers of 
Sprague Dawley rats fed with a high cholesterol and fat diet was identified. 
The administration of berberine modified the hepatic cholesterol biosynthesis, 
resulted in a shift in the metabolism of fatty acids in the liver, heart and kidney 
of the rats in the treated group. At the same time, an alternative carbohydrate 
metabolism which involved myo-inositol, and D-ribose could also has 
occurred. Finally, a shift in transamination and amino acid biosynthesis in the 
rat kidney but not in other organs was proposed. It is apparent that berberine 
modified the metabolic profiles differently for Sprague Dawley rats fed with a 
high cholesterol and fat diet compared to a normal diet. Hence, our results 
show that the application of metabolomics has the potential to improve the 
understanding of the complex process of atherosclerosis, which may enable 
the development of personalized diagnostic and therapeutic approaches.  




Chapter 5 Metabolomic and metallomic study of rat urine and 
serum from both hypercholesterolemic and non-
hypercholesterolemic rats after berberine injection 
5.1 Introduction 
Berberine (BBR) is an isoquinoline alkaloid with a bright yellow colour easily 
seen in most of the herb materials that contain any siginificant amount of this 
compound. BBR is the main component of an ancient Chinese herb Coptis 
chinensis French, and extracts of BBR-containing plants have been used for 
many centuries in the treatment of diarrhoea, intestinal parasite infections and 
ocular trachoma (153, 173, 174). It also possesses cholesterol lowering 
property which is achieved through the downregulation of the expression of 
genes involves in lipogenesis as well as upregulation of those involved in 
energy expenditure in adipose tissue and muscle (175). In previous studies, the 
effect of berberine on the hypercholesterolemic animal model was evaluated 
through the investigation of some targeted compounds (161-163). 
Nevertheless, studies reporting on the comprehensive metabolic and 
metallomic profile changes with the use of analytical platforms such as 1H 
NMR and ICP-MS, associated with the administration of BBR are by far 
limited. 
Metabolomics, an emerging field of biomedical research, is the quantitative 
measurement of the dynamic multiparametric metabolic response of living 
systems to pathophysiological stimuli of genetic modification (140). 
Metabolomics relies on the improvement of analytical techniques and data 




handling systems. Nuclear magnetic resonance (NMR) is the most frequently 
used analytical tools for the metabolomics as it is non-destructive, non-biased, 
and easily quantifiable; it requires minimal sample preparation and permits the 
identification of novel compounds. Currently, high-resolution NMR has been 
used extensively for metabolic profiling of mouse or rat urine for the 
monitoring of diet effects and evaluation of toxicity of chemical substances 
(143, 176-181). Metabolomic studies usually involves the use of an 
unsupervised pattern recognition tool such as Principal Component Analysis 
(PCA), which is essential in aiding the visualization of high dimensional data 
obtained in metabolomic and metallomic studies (182). 
Metallomics, on the other hand, represents a new scientific field in order to 
integrate the research fields related to biometals (92). Metallomics should be a 
scientific field in symbiosis with genomics, proteomics and metabolomics, 
because syntheses and metabolic functions of genes and proteins cannot be 
performed without the aid of various metal ions and metalloenzymes. In 
metallomics, the metal-containing biomolecules are defined as ―metallomes‖, 
in a similar manner to metabolomes in metabolomics. Since the identification 
of metallomes and elucidation of their biological or physiological functions in 
the biological systems is the main research target of metallomics, chemical 
speciation for specific identification of bioactive metallomes is one of the 
most important analytical technologies to establish metallomics as the 
integrated bio-metal science. ICP-MS is often used in such studies to speciate 
the metallomes since it is a powerful technique for trace and ultratrace analysis 




of biological samples and especially of body fluids combining rapid analysis 
with excellent detection limits and multi-element capabilities (183).   
In this study, NMR-based metabolomic analysis and ICP-MS-based 
metallomic analysis are combined and applied in conjunction with 
multivariate statistics to examine the metabolic and metallomic changes in rat 
to investigate the berberine effect. Efforts were made on the 
hypercholesterolemic rat model to study both the metabolomic and metallomic 
changes after the administration of BBR. The deconvolution of the 
metabolome and metallome changes related to BBR in hypercholesterolemic 
rats was also carried out. By understanding the biochemical pathway cha nges 
induced by BBR, it might be possible for us to postulate both the beneficial 
and harmful effects of BBR administration.  
5.2 Materials and methods 
5.2.1 Chemicals 
Pure deionized water was obtained from Millipore Alpha-Q water system 
(Bedford, MA, USA). Berberine, deuterated water (D2O, containing 0.03wt% 
3-(trimethylsilyl) propionic-acid, sodium salt, TSP) were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). 65% nitric acid was purchased from 
Merck (Darmstadt, Germany). Standard solutions containing alkali metals, 
alkaline earth metals, transition metals and rare metals for use in ICP-MS 
calibration were purchased from Inorganic Venture (Virginia, USA).  
5.2.2 Animal Study 




Male rats (Sprague Dawley) were obtained from Laboratory Animals Centre, 
National University of Singapore (NUS). All of the animal experiment 
protocols used in this experiment complied with the institutional guidelines of 
NUS International Animal Care and Use Committee (IACUC). The animals 
were acclimatized in standard rodent cages with individual ventilation. The 
animal room was maintained at 25  2ºC with natural day/night cycle. High-
fat and high-cholesterol (HFHC) diet, containing 2% cholesterol, 5% fat and 
18% protein in pellet form (Harlan Teklad, USA), was provided to all 
hypercholesterolemic rats (14 rats). Water was also provided ad libitum. 
Hypercholesterolemic rats were randomly allocated into control and treated 
groups respectively (comprising 8 animals in control group and 6 animals in 
treated group of hypercholesterolemic rats) following a 28-day acclimatization 
period. The treated group was administered with BBR at a dose of 50 mg/kg 
while the control group received saline, both via intraperitoneal (IP) injection 
at 0 and 48 hours. The median lethal dose (LD50) value of IP administration of 
BBR is 500 mg/kg (184). All animals were housed individually in metabolism 
cages for the ease of urine collection. Samples of rat urine were collected 
during the same time period from 9am to 12pm daily for a total of 4 days after 
BBR treatment. After the blood serum collection, all animals were sacrificed 
at the end of the experiment via carbon dioxide asphyxiation.  
5.2.3 Sample preparation of urine samples for 1H NMR 
In order to look for meaningful differences between the control and treated 
group, focus is placed on samples collected 1 day after BBR injection, referred 




to as ―Day 2‖ and ―Day 4‖ in this study. Analysis of urine samples on the day 
of BBR injection would definitely result in a significant difference between 
the dose groups due to the presence of BBR metabolites present in the treated 
group. However, since these BBR metabolites would have broken down 24 
hours after injection, analysis of urine samples 1 day after injection can then 
allow us to ascertain if BBR really causes a change in rat metabolism. The rat 
urine collected from the control and treated group were stored frozen at 20ºC 
prior to analysis. Before 1H NMR analysis, 300μL of the thawed urine samples 
were buffered with 300μL of 0.2 M phosphate buffer/D2O (containing TSP) at 
pH 7.4. The solutions were pipetted into NMR tubes (5mm O.D., 7 inch length, 
Sigma-Aldrich) before 1H NMR analysis. 
5.2.4 Sample preparation of serum samples for ICP-MS  
Before ICP-MS analysis, freeze-dried serum was first prepared by adding 2.4  
mL of deionized water to 0.3 mL of thawed serum. This diluted mixture was 
frozen in fridge and then freeze-dried using a benchtop manifold freeze-drier. 
10 mL of 0.14 M nitric acid was added to the freeze-dried serum and the 
mixture was centrifudged before transferring the supernatant for ICP-MS 
analysis. Such a sample preparation method has the advantages of being less 
time-consuming and introducing less contamination (183). 
5.2.5 Analysis of urine samples for 1H NMR 
One dimensional 1H NMR spectra for urine samples were obtained on a 
Bruker DRX500 operating at 500.15 MHz observation frequency and 
equipped with TXI cryoprobe. Solvent suppression was achieved by applying 




the standard Noesypresat pulse sequence (Bruker Biospin Ltd) with secondary 
irradiation of the dominant water signal during the mixing time of 150 ms and 
the relaxation delay of 2 s. Spectra were referenced to the internal reference 
standard TSP to provide a field-frequency lock. 
5.2.6 Analysis of serum samples for ICP-MS  
A model 7500cx ICP-MS instrument (Agilent Technologies, USA), which 
included a quadrupole mass spectrometer, was used for the determination of 
bio-metals in serum samples. The instrumental components and operating 
conditions for the ICP-MS instrument are summarized in Table 5.1. The LOD 
for each element measured in this study is in ppt level; their RSD (n=6) is less 














Table 5. 1 Instrumental components and ICP-MS operating conditions. 
ICP-MS instrument Model 7500cx from 
Agilent 
Technologies 
Plasma conditions  
RF Power 1500 W 
RF Matching 1.80 V 
Sampling Depth 8.0 mm 
Torch-H 0.0 mm 
Torch-V -0.2 mm 
Carrier Gas 0.70 L/min 
Makeup Gas 0.30 L/min 
Nebilizer pump 0.10 rps 
Ion Lenses  
Extract 1 0 V 
Extract 2 -150 V 
Omega Bias  Ce 0 V 
Omega Lens  Ce -30 V 
Quadrupole Focus 5 V 
Cell Exit  -30 V 
Quadrupole Parameters  
Quadrupole Bias -3 V 
Octupole Parameters  
Octupole RF 180 V 
Octupole Bias -3 V 
 
5.2.7 Chemometric Analysis  
Fourier transformed 1H NMR spectra were manually phased and baseline 
corrected using the 1DWINNMR software (Bruker Biospin). Each spectrum 
was integrated between 0.5 to 4.5 and 5.1 to 10 ppm. The spectral region 
containing the water resonance was removed from all data sets prior to 
normalization and multivariate data analysis in order to eliminate variation due 
to suppression efficiency. The resulting two-dimensional data, 1H chemical 
shift, and peak heights were generated.  




All data exported from 1H NMR was normalized to account for any 
differences inherent in samples. The normalization step is crucial prior to 
further data analysis because it can greatly influence outliers and overall 
dataset projection by a chosen algorithm. 
From the normalized data obtained from 1H NMR, indication of significance 
was based on a two-tailed student t-test performed with Microsoft Excel 
software (Microsoft Corporation, USA). For the identification of potential 
biomarkers, two-tailed student t-test (p < 0.05, p < 0.01 and p < 0.001) was 
used. 
The resulting normalized data were then exported to Simca-P+ Software 
package (Umetrics, Umea, Sweden) for subsequent processing by 
unsupervised method. For PCA, the data are reduced to two latent variables 
(or principal components, PCs) that will describe maximum variation within 
the data. The PCs which are obtained from the scores will highlight clustering, 
trends and outliers in the observation direction of data set.  
5.3 Results and discussion 
5.3.1 Metabolic fingerprinting of rat urine samples in 
hypercholesterolemic rat model by 1H NMR 
Metabolomic approach using 1H NMR and multivariate analysis is often used 
to study metabolic differences associated with gene function and 
pathophysiological and toxicological stimuli. To investigate the effect of BBR 
administration in rats, urine samples collected on Day 2 (1 day after 1st dose of 




BBR injection) were analyzed using 1H NMR. Typical 1H NMR spectra for rat 
urine samples from both the control and BBR-treated groups of 
hypercholesterolemic rats are shown in Figure 5.1 A and B. Simple visual 
inspection of the spectra suggested that the two groups may each have a 
unique metabolic profile, since both demonstrated quantitative as well as 
qualitative differences. Dominant changes were observed in the regions o f δ: 
2.3-2.7, 2.9-3.1 and 3.5-4.0 ppm. However, further visual comparison of the 
two spectra was difficult because of inter-rat variations in the urine 
composition, the complexity of the spectra and differences in the volume of 
urine excreted. Thus, a multivariate statistical method such as PCA was 
applied to the NMR data, using total integral normalization as well as 







Figure 5. 1 1H NMR spectra of rat urine samples from (A) control and (B) 
BBR-treated groups in hypercholesterolemic model.  




The PCA score plots obtained after normalization to total integral and after 
normalization to creatinine integral were shown in Figure 5.2 A and B 
respectively. In metabolomic studies, before analyzing NMR spectral data of 
urine samples, adequate normalization is indispensable in order to remove or 
minimize the effects of variable dilution of the samples so as to allow for 
meaningful comparisons between samples (185). Normalization to total 
integral is the most common approach in metabolomics and it involves 
dividing each element in each spectrum by the total intensity of the spectrum, 
thereby forcing the sum of each spectrum to one (186). The PCA score plot 
after normalization to total integral is shown in Figure 5.2 A. When data is 
normalized to creatinine, a single component (i.e. creatinine) is used as a 
surrogate for all endogenous metabolites in the sample. Since typical 
biological variation for creatinine is small (2-fold) within a homogenous 
population such as Sprague-Dawley rats on a fixed diet, creatinine is often 
used as an indicator of urine concentration. The PCA score plot after 
normalization to creatinine is shown in Figure 5.2 B. Here, better separation 
between the treated groups as well as least variation between the biological 
replicates is observable. Both PCA plots in Figure 5.2 show that the metabolite 
profiles of urine samples obtained from the control group were clearly 
different from those of the BBR-treated group irrespective of the 
normalization methods since both groups are able to cluster separately. This 
indicates there are indeed differences between the two groups.  
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Figure 5. 2 PCA score plots based on 1H NMR analysis of urine samples 
collected on day 2 from hypercholesterolemic rat: (A) After normalization to 
total integral (R2X[1]=0.317569, R2X[2]=0.163469),  (B) After normalization 
to creatinine signal (R2X[1]=0.348288, R2X[2]=0.168605). 
 
Selected metabolites present in urine samples of hypercholesterolemic rats 
collected on Day 2 detected by 1H NMR were summarized in Table 5.2. Most 
of the compounds detected included amino acids, carboxylic acids, 
trimethylamines and others. Based on a two-tailed student’s t-test, major 
metabolites perturbed in BBR-treated group include pyruvate, succinate, 
glutamate, trimethylamine and creatinine. Table 5.2 also shows a comparison 
of the type of change in the metabolites observed in the BBR-treated rats with 
respect to the control rats when 1H NMR data were normalized to total integral 
and creatinine (Table S5.1 and S5.2 in Appendix 2 listed the metabolites peak 




intensities after normalized to total integral and creatinine respectively). It can 
be observed that the major metabolic changes observed fairly agreed with each 
other in both normalization methods despite some inconsistencies (choline and 
glycine) which were denoted by †. However, it was also noted that the type of 
change observed for these chemical shift values showing inconsistencies are 
not statistically significant anyway since they have p values of more than 0.05 
based on the student’s t-test. As urine volume can vary widely based upon 
water consumption and other physiological factors like health and body mass, 
and the concentrations of endogenous metabolites in urine would vary widely, 
hence this 2-way normalization strategy could confirm the urinary 
metabolomic changes owing to BBR injection.  
 
Table 5. 2 Selected metabolites identified in hypercholesterolemic rat urine 
samples collected on Day 2 as measured by 1H NMR normalizing to both total 





Normalization Strategy  
Normalized to total 
integral 













3-D-Hydroxybutyrate  1.203 (d)**  1.203 (d)*  
Lactate 1.327 (d)  1.327 (d)  
Acetate 1.923 (s)**  1.923 (s)  
Glutamate 2.347 (m)***  2.347 (m)  
Pyruvate 2.409 (s)***  2.409 (s)***  
Succinate 2.422 (s)***  2.422 (s)**  
Glutamine 2.445 (m)***  2.445 (m)***  
Citrate 2.722 (d)  2.722 (d)*  




Hypotaurine 3.352 (t)**  3.352 (t)  
Trimethylamine 2.886 (s)***  2.886 (s)*  
Creatine 3.047 (s)***  3.047 (s)*  
 3.930 (s)***  3.930 (s)**  
Creatinine 4.057 (s)*  4.057 (s)  
Dimethylglycine 2.931 (s)  2.931 (s)  
Phenylalanine 7.424 (m)**  7.424 (m)*  
 3.120 (m)  3.120 (m)***  
Choline
†
 3.204 (s)  3.204 (s)  
Phosphocholine 3.232 (s)***  3.232 (s)  
Trimethylamine N-oxide 3.269 (s)  3.269 (s)**  
Taurine 3.427 (t)  3.427 (t)  
Glycine
†
 3.567 (s)  3.567 (s)  
Lysine 3.765 (t)  3.765 (t)  
Tyrosine 7.191 (m)  7.191 (m)**  
 7.161 (m)**  7.161 (m)  
Hippurate 7.642 (t)  7.642 (t)  
 7.554 (t)  7.554 (t)  
 3.970 (d)  3.970 (d)  
Formate 8.464 (s)  8.464 (s)  
Alanine 1.478 (d)***  1.478 (d)  
Phenylacetylglutamine 7.410 (m)**  7.410 (m)  
Betaine 3.893 (s)*  3.893 (s)  
Glucose
†
 3.255 (m)  3.255 (m)  
 3.500 (m)***  3.500 (m)  
Tryptophan 7.176 (d)  7.176 (d)  
 7.294 (d)*  7.294 (d)  
 7.538 (d)  7.538 (d)  
† 
Metabolites with opposing type of change observed when raw 
1
H NMR data is 
normalized to total integral and to creatinine. The statistics are as follows: Significant 
difference between control group (n=8) and treated group (n=8) is based on two tailed 
student’s t test (* p0.05, ** p0.01, *** p0.001). A lower p value represents a 








5.3.2 Metallomic fingerprinting of rat blood serum samples in 
hypercholesterolemic rat model by ICP-MS 
The chemistry of a cell needs to be characterized not only by its characteristic 
genome in the nucleus and protein content, but also by the distribution of the 
metals and metalloids among the different cell compartments (187). A 
complete fingerprint of the metal-binding components in a cell is likely to 
provide a new insight into the role of metal ions in biochemistry. ICP-MS is a 
powerful technique often used in metallomics studies to determine different 
elements in serum samples. In this study, ICP-MS analysis of serum samples 
from hypercholesterolemic rat collected on the day of sacrifice was performed 
and the PCA score plot obtained is shown in Figure 5.3. Like the plots 
obtained from metabolomic study using 1H NMR (Figure 5.2), clear separation 
between the control and BBR-treated group could also be observed from this 
plot. This indicates that ICP-MS is successful as a technique to detect 
differences in the levels of bio-metals present in the two dose groups. The 
observed changes in bio-metals in blood serum samples were summarized in 
Table 5.3 (Table S5.3 in Appendix 2 listed the concentrations of selected bio-
metals). Major bio- essential elements perturbed in the BBR-treated group as 
compared to the control group are sodium, potassium, vanadium and 
manganese. 
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Figure 5. 3 PCA score plot based on ICP-MS analysis of blood serum samples 
collected on day of sacrificial from hypercholestero lemic rat 
(R2X[1]=0.274331, R2X[2]=0.173527). 
 
Table 5. 3 Selected bio-elements identified in hypercholesterolemic rat blood 
serum samples collected on day of sacrificial for both control and treated 
groups as measured by ICP-MS. 
Elements Type of 
change  
Elements Type of 
change  
Elements Type of 
change  
Li*  As  Dy  
Be  Rb***  Ho  
B**  ‡ Sr  Tm  
‡ Na***  Y*  Lu  
‡ Mg   Nb  Hf  
Al  Rh*  Ta**  
‡ K***  In**  Pt  
Sc*  Cs**  Au  
‡ V**  Ba  Bi*  
‡ Mn*  Gd  Th  
‡ Fe  Tb  U  
The statistics are as follows: Significant difference between control group (n=8) and 
treated group (n=6) is based on two tailed student’s t test (* p0.05, ** p0.01, *** 
p0.001). Elements marked with ‡  are bio-essential. A lower p value represents a 
more significant change resulted. The type of change  and  is for treated group of 
hypercholesterolemic rats compared to control group. 





5.3.3.1 Discussion on the metabolome changes 
One of the aims of this current work is to make use of 1H NMR to probe the 
metabolic profile changes in hypercholesterolemic rats with the administration 
of BBR. Overall, detectable and dynamic changes in the metabolome of BBR-
treated rats, especially in cellular pools of carbohydrates, amino acids and 
fatty acids were detected after BBR treatment. PCA score plots obtained 
(Figure 5.2) showed distinct differentiation between the control and BBR-
treated groups. This indicates that there is a unique biochemical profile 
associated with each dose group, which can be effectively used to distinguish 
between them. 
Alterations in metabolite profile can be considered the ultimate cellular 
consequence of environmental perturbations (188). For clarity, the type of 
change of metabolism perturbed presented in the following is based on urine 
samples collected from hypercholesterolemic rats on Day 2. The relevant 
changes for the metabolites are tabulated in Table 5.2. 
Fatty acids metabolism 
In BBR-treated rats, an increase in levels of ketone bodies like acetate and 3-
D-Hyroxybutyrate was observed. Ketone bodies are chemicals that are 
produced as by-products when fatty acids are broken down by most of the 
tissues in the body for energy (189). The increase in ketone bodies may arise 




from increased partial β-oxidation of fatty acids in the liver and skeletal 
muscle, thereby producing more ketone bodies.  
Methylamine metabolism and osmoregulat ion  
In this study, increase in levels of methylamines like dimethylamine and 
trimethylamine in BBR-treated rats is observed and this is indicative of a 
change in the balance of methylamine metabolism. Methylamines are 
important osmoregulatory compounds. Osmoregulation is the regulation of 
water and ion concentrations in the body in order to keep the organism's fluids 
from becoming too diluted or too concentrated. Increase in methylamines 
levels in BBR-treated rats was consistent with increase in levels of choline and 
this indicates that osmoregulation may be affected. This may suggest that 
methylamine metabolism was altered, possibly as an osmotic compensation 
for changes in major metabolites like carbohydrates, amino acids and fatty 
acids due to BBR treatment.  
Krebs cycle  
Krebs cycle is the common pathway by which organic fuel molecules of the 
cell are oxidized during cellular respiration for the generation of energy. The 
importance of the Krebs cycle lies in the efficiency with which it captures 
energy released from nutrient molecules and stores it in a usable form (190). 
In this study, a shift in Krebs cycle after BBR administration was proposed as 
levels of related metabolites like succinate, acetate and glucose were increased. 
It is possible that the correlated increase in urinary concentrations of Krebs 
cycle intermediates reflect either systemic stress produced by BBR or local 




effects on kidney tubular transport. Illustrated on Figure 5.4 is a metabolite 
linkage map representing the Krebs cycle as well as other related metabolic 
pathways. The type of change observed for some related metabolites is also 
indicated in Figure 5.4 (191).  
 
Figure 5. 4 PCA linkage map representing the Krebs cycle and Na+/K+ pump 
as well as other related metabolic pathways involved with BBR administration. 
Red arrows (  ) indicate an increase in levels of metabolites in BBR-treated 
group as compared to control group detected by 1H NMR while green arrows 
(  ) indicate an increase in levels of bio-metals in BBR-treated group as 
compared to control group detected by ICP-MS. The abbreviations are as 
follows: NAD+ and NADH mean Nicotinamide Adenine Dinucleotide in the 
oxidised and reduced form respectively; FAD and FADH2 mean Flavin 
Adenine Dinucleotide in the oxidised and reduced form respectively; ATP 
means Adenosine Triphosphate; ADP means Adenosine Diphosphate and P i 
means a phosphate squares. 




5.3.3.2 Discussion on the metallome changes 
Another aim of this current work is to make use of ICP-MS to probe the 
metallomic profile changes in hypercholesterolemic rats after the 
administration of BBR. In previous studies, it has been elucidated that various 
elements play essential roles in various biological systems since most of trace 
metals in biological fluids and organs are binding with various proteins called 
―metalloproteins‖ (92). As such, metallomics has been postulated to be 
considered at the same level of scientific significance as genomics or 
proteomics (187). The combined studies of metabolomics and metallomics 
could enhance the understanding of the whole molecular biosystems.  
In Table 5.3, it was observed that BBR has resulted in statistically significant 
changes of some biologically important metals in BBR-treated rats. Increase in 
level of vanadium (V) observed is indicative of changes in cholesterol and 
glucose metabolism due to BBR treatment. Studies on V consistently suggest 
that V may act as a co-factor for enzymes involved in blood sugar, lipid and 
cholesterol metabolism, hormone production and neurotransmitter metabolism 
(192). A century ago, the element V was already used in diabetes mellitus  
(193). This element could be considered as an essential element (194) to 
improve glucose- insulin metabolism (195, 196). It was also reported that V 
seems to block protein tyrosine phosphatase with the consequent increment in 
insulin sensitivity in Type 2 Diabetes Mellitus patients (197).  
In addition, decrease in level of manganese (Mn) in BBR-treated rats suggests 
that BBR may perturb lipids metabolism. Mn has been shown to increase 




gluconeogenesis in vitro due to its integral role in pyruvate carboxylase, a Mn 
metalloenzyme, and phosphoenolpyruvate carboxykinase, a Mn-activated 
enzyme (198). Gluconeogenesis is the conversion of non-carbon substrates 
like amino acids and lactate into glucose. A decrease in Mn level thus reflects 
a down-regulation of gluconeogenesis to prevent the production of more 
glucose. As such, both the increase in V leading to greater insulin sensitivity 
and decrease in Mn level leading to less gluconeogenesis ultimately keep the 
blood glucose level under control and this is consistent with BBR being used 
as an anti-diabetic drug in previous reports.  
Of all elements detected by ICP-MS, both sodium (Na) and potassium (K) 
showed the largest change in the BBR-treated rats with respect to the control 
group based on a two-tailed student’s t test performed, with p value of less 
than 0.001. Both these bio-metals are involved in the Na+/K+ exchange pump, 
which is found in the membranes of many types of cells.  In particular, it plays 
a very important role in nerve cell membranes as they are necessary to 
generate electrical impulses which lead to nerve impulses (199). Since the 
Na+/K+ pump illustrates "active transport" as it moves Na+ and K+ against their 
concentration gradients, energy is required and is supplied by ATP molecules. 
ATP required for this active process is generated from Krebs cycle, which 
produces ATP via the breakdown of glucose. As seen from Table 5.3, increase 
in levels of Na and K is observed and this may suggest an elevation in the 
Na+/K+ pump activity. This is consistent with the previously mentioned 
speculation that BBR may have resulted in an up-regulation of Krebs cycle as 
seen by an increase in Krebs cycle-related metabolites, as detected by 1H 




NMR. An elevated Krebs cycle activity would result in more ATP molecules 
being produced, which then in turn lead to an up-regulation of the activity of 
ATP-dependent Na+/K+ pump. The metabolic relationship between the Krebs 
cycle and Na+/K+ pump is illustrated in Figure 5.4. 
5.4 Concluding remarks 
In this current study, a method based on 1H NMR and ICP-MS has been 
developed for metabolic and metallomic fingerprinting of rat biological fluids 
after BBR injection. Such a multi-analytical platform with the integration of 
metabolomic with metallomic studies is an unprecedented analytical approach. 
It serves to give us greater insight into the type of modulation in the biological 
system in rat with BBR administration due to a more extensive coverage of 
biological species. The results obtained indicated that major metabolic 
processes like Krebs cycle, amino acid metabolism, cholesterol metabolism 
and osmoregulation in rat are perturbed with BBR administration. The 
proposed approach combined with pattern recognition tools like PCA provided 
a more comprehensive picture of the metabolic and metallomic changes 
induced by BBR. Overall in this study, the results obtained were information 
rich and provides a firm platform for future progress into this novel yet 
practical aspect. 




Chapter 6 Conclusion and future work 
This dissertation mainly focused on the study of herbal medicines. The results 
indicated that modern analytical techniques, such as PHWE, LC-MS, GC-MS, 
ICP-MS and NMR, are powerful tools for the investigation of natural products 
in many aspects, including the determination of the toxic compounds, quality 
control and metabolic effects.  
6.1 Summary of results  
First, in Chapter 2, the combination of HPLC with orbitrap mass spectrometry 
allowed for the rapid and accurate determination of pyrrolizidine alkaloids 
such as lycopsamine in botanical extracts. At the same time, the MSn spectra 
gave characteristic ions that are useful for the identification of PAs in 
unknown samples. Subsequently, quantitative analysis of lycopsamine in 
comfrey was carried out, which has seldom been reported previously. The 
extraction of lycopsamine from comfrey was studied by evaluating different 
methods, including sonication extraction, pressurized hot water extraction and 
heating under reflux; and it is observed that heating under reflux was more 
effective compared with PHWE in this case. The results obtained show that 
LC-ESI-obitrap MS provides a powerful method for the identification and 
determination of hepatotoxic pyrrolizidine alkaloids in botanicals and dietary 
supplements. In addition, our results provide new insights into the 
understanding and practical application of PHWE. 
In Chapter 3, our work indicates that PFE/PHWE is capable of effective 
extraction of bioactive compounds from chrysanthemum with both MeOH and 




water as extraction solvents. Under the optimized PFE/PHWE conditions, 
establishment of chrysanthemum profiles by HPLC-UV and data processing 
by unsupervised multivariate procedures based on PCA allowed for the 
digitalization of chrysanthemum properties, providing a novel approach for the 
objective annotation of different chrysanthemum attributes such as species, 
provenance and quality. Furthermore, a clearer separation and classification 
were obtained with the environmentally-benign water extracts compared with 
the MeOH extracts. Thus our study offered a new perspective on the quality 
control of botanicals and medicinal plants. In any industrial applications of 
plant extraction and analysis, economic and environmental considerations 
frequently outweigh the other benefits; hence, PHWE with the use of the 
inexpensive and non-toxic water and automated instrumentation is the ideal 
alternative for large-scale extraction. 
Next, in Chapter 4, the use of both 1H NMR and GC-MS with pattern 
recognition tools provides a comprehensive picture of metabolic changes in 
the tissue samples between the two groups. The current approach is robust and 
reproducible, which will not add additional resources to existing in-vivo 
studies. A set of biomarkers in the liver, serum, heart and kidney samples 
associated with the weight loss and cholesterol lowering effects of berberine in 
the livers of Sprague Dawley rats fed with a high cholesterol and fat diet was 
identified. The administration of berberine modified the hepa tic cholesterol 
biosynthesis and a shift in the metabolism of fatty acids in the liver, heart and 
kidney of the rats in the treated group. At the same time, it tapped on 
alternative carbohydrate metabolism which involved myo-inositol, D-ribose. 




Finally, a shift in transamination and amino acid biosynthesis in the rat kidney 
without affecting other organs was proposed. It is apparent that berberine 
modified the metabolic profiles differently for Sprague Dawley rats fed with a 
high cholesterol and fat diet compared to a normal diet. Hence, we propose 
that the application of metabolomics has the potential to improve the 
understanding of the complex process of atherosclerosis, which may enable 
personalized diagnostic and therapeutic approaches.  
In Chapter 5, the metallomic approach based on ICP-MS has been developed 
in aid of the investigation of the metabolic effect of berberine. This multi-
analytical platform with the integration of metabolomic with metallomic 
studies is an unprecedented analytical approach. It serves to give us greater 
insight into the type of modulation in the biological system in rat with 
berberine administration due to a more extensive coverage of biological 
species. The results obtained indicated that major metabolic processes like 
Krebs cycle, amino acid metabolism, cholesterol metabolism and 
osmoregulation in rat are perturbed with berberine administration. The 
proposed approach combined with pattern recognition tools like PCA provided 
a more comprehensive picture of the metabolic and meta llomic changes 
induced by berberine. 
6.2 Limitation and future work 
With the work presented in this dissertation, modern analytical techniques, 
such as PHWE, LC-MS, GC-MS, and NMR are proved to be powerful tools 




for herbal medicine studies. However, several areas would still need to be 
improved in further research: 
1. Pesticides and herbicides have been widely used in agriculture to fight 
against insect, pests, weeds and moulds for many years, thereby increasing 
crop productivity. Besides their positive effects, they also have been posing 
various health risks to consumers. Versatile use of pesticides and herbicides 
has resulted in contamination of all basic necessities of life including herbal 
plants. In response to this, analytical methods should be developed for the 
quantification and monitoring of multiple pesticide and herbicide residues in 
herbal medicines (200). It is an important research area for the evaluation of 
the toxicity and quality control of herbal medicines. Hence, it is strongly 
encouraged to conduct a study on the determination and monitoring of 
multiple pesticides and herbicides in the future. As the analytical methods 
proposed in the current work have been proved to be powerful, it would be 
desirable to use these methods in the determination and monitoring of 
pesticides and herbicides. 
2. It is clear that metabolomics is a burgeoning science and there is still a 
great deal to do. First, metabolomics has potential applications across the 
spectrum of pharmaceutical development. In our current study, the efficacy of 
berberine has been studied; efforts should be made to delineate the 
toxicity/safety assessment of berberine in future. Second, the integration of 
metallomics and metabolomics has given us an opportunity to understand the 
metabolic effect of berberine more deeply; further studies on the integration of 
metabolomics into proteomics and genomics are anticipated and these may 




provide a more comprehensive and insightful view in pharmaceutical and 
clinical studies (201). Third, as some difficulties of data processing and 
standardization were encountered in our work, hence the validation work and a 
simplified system to present data is necessary before the metabolic tools can 
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Figure S4.1 Typical GC-MS Total Ion Chromatograms (TIC) of the lipid fraction of 
hypercholesterolemic rat (A) Liver, (B) Serum, (C) Heart and (D) Kidney extracts. 
(Pink: Control group, Blue: Treated group) 





Figure S4.2 Typical spectra of aqueous fraction of (A) tissue extracts and (B) serum 
samples from hypercholesterolemic rats as measured by 
1
H NMR.  





Figure S4.3 Typical NMR spectra of tissue lipid fraction from hypercholesterolemic 
rats as measured by 
1















Table S4.1 Metabolites identified in rat liver samples for both the control group and 






Normalized peak intensity %
a
 
Control (n=8) Treated (n=6) 
Mean  SD Mean  SD 
1 8.26 L-Serine 0.363 0.0752 0.523 0.114 
2 11.91 L-Proline 0.00956 0.00241 0.0109 
0.0016
3 
3 14.99 D-Ribose *** 0.177 0.0476 0.355 0.100 
4 16.69 Ribitol *** 0.0177 0.00252 0.0259 
0.0044
9 
5 17.38 Phosphoric Acid 0.00838 0.00724 0.00920 
0.0082
3 
6 18.16 D-Mannopyranose* 0.0178 0.00431 0.0126 
0.0045
4 
7 21.96 Glucose 0.0224 0.0112 0.0125 
0.0099
8 
8 24.10 Myo-inositol ** 0.297 0.133 0.507 0.0893 
9 24.28 
Octadecanoic acid, 
Stearic acid ** 




0.220 0.0490 0.293 0.0608 
11 38.48 Cholesterol 0.0193 0.0217 0.0129 0.0149 
a
The relative intensity of metabolites is expressed with their normalized peak height. 
Values are represented as mean ± SD (standard deviation). The statistics are as 
follows: significance difference between the control group (n=8) and treated group 
(n=6) is based on two tailed student t test (* p<0.05, ** p<0.01, ***p<0.001). 
 




Table S4.2 Metabolites identified in rat serum samples for both the control group and 






Normalized peak intensity %
 a
 
Control (n=8)  Treated (n=6) 
Mean  SD Mean  SD 
1 6.44 Urea 2.99 0.512 3.10 0.848 
2 9.30 L-threonine* 0.283 0.0968 0.144 0.0790 
3 12.32 L-Proline 0.390 0.0926 0.321 0.0755 
4 15.13 Thiourea* 0.330 0.108 0.570 0.213 
5 19.4 Glucofuranoside *** 6.78 1.61 2.59 1.20 
6 20.37 Glucose 11.1 3.07 10.6 1.74 
7 20.64 D-Xylopyranose ** 3.95 1.53 1.27 0.594 












9.47 2.24 15.3 5.36 
12 40.83 Cholesterol 1.59 0.583 1.85 0.636 
a
The relative intensity of metabolites is expressed with their normalized peak height. 
Values are represented as mean ± SD (standard deviation). The statistics are as 
follows: significance difference between the control group (n=8) and treated group 
(n=6) is based on two tailed student t test (* p<0.05, ** p<0.01, ***p<0.001). 
 




Table S4.3 Metabolites identified in rat heart samples for both the control group and 






Normalized peak intensity %
 a
 
Control  (n=8)  Treated (n=6) 
Mean  SD Mean  SD 
1 6.48 Urea 1.44 0.340 1.20 0.335 
2 8.76 L-Serine 0.353 0.0923 0.366 0.117 
3 12.32 L-Proline 0.549 0.076 0.545 0.117 




0.272 0.0590 0.509 0.0289 
6 18.53 9H-Purine *** 2.30 0.180 1.65 0.142 
7 18.60 D-Mannopyranose *** 0.707 0.252 1.47 0.348 
8 18.74 D-Fructose ** 0.402 0.0704 1.35 0.748 
9 20.37 Glucose 5.48 0.649 5.19 0.829 
10 24.09 Myo-Inositol* 0.617 0.197 0.885 0.128 




0.861 0.206 1.34 0.280 
13 34.91 2-Monostearin* 0.475 0.0396 0.530 0.0541 
14 40.90 Cholesterol 3.86 0.375 3.83 0.564 
a
The relative intensity of metabolites is expressed with their normalized peak height. 
Values are represented as mean ± SD (standard deviation). The statistics are as 
follows: significance difference between the control group (n=8) and treated group 
(n=6) is based on two tailed student t test (* p<0.05, ** p<0.01, ***p<0.001). 
 




Table S4.4 Metabolites identified in rat kidney samples for both the control group and 






Normalized peak intensity %
 a
 
Control  (n=8) Treated  (n=6) 
Mean  SD Mean  SD 
1 6.53 Urea 2.36 0.803 2.25 0.652 
2 9.29 L-threonine* 0.825 0.302 0.461 0.0799 
3 12.32 L-Proline 1.42 0.390 1.15 0.649 
4 12.90 Alanine*** 0.0867 0.0148 0.0509 0.00839 
6 20.15 Tyrosine** 0.165 0.0554 0.0777 0.0264 




4.64 0.529 5.68 0.583 








1.63 0.184 1.63 0.117 
12 29.66 D-Myo-inositol* 0.512 0.109 0.368 0.0452 
13 40.99 Cholesterol 6.89 0.637 6.90 0.402 
a
The relative intensity of metabolites is expressed with their normalized peak height. 
Values are represented as mean ± SD (standard deviation). The statistics are as 
follows: significance difference between the control group (n=8) and treated group 
(n=6) is based on two tailed student t test (* p<0.05, ** p<0.01, ***p<0.001). 
 






H chemical shift and multiplicity assignment of the metabolites identified 
in aqueous fraction of liver samples for both control and treated group as measured 
by 
1
H NMR spectroscopy. 
Key Metabolites 
 1H (ppm) 
and 
Multiplicity 
Normalized Peak Intensity %
 a
 
Control (n=8) Treated (n=6) 
Mean  SD Mean  SD 
1 Leucine 0.94 (d)* 0.339 0.0345 0.297 0.0293 
2 Valine 1.04 (d) 0.398 0.0497 0.372 0.0515 
  3.60 (d) 0.827 0.190 0.590 0.256 
3 Isoleucine 0.99 (t) 0.461 0.0527 0.435 0.0549 
  1.02 (d) 0.253 0.0280 0.252 0.0297 
4 Lactate 1.33 (d) 1.42 0.357 1.54 0.250 
5 Acetate 1.91 (s) 0.134 0.0213 0.133 0.0239 
6 Lipids 2.00 (m) 0.162 0.0178 0.149 0.0175 
7 Glutamate 2.08 (m) 0.201 0.0286 0.211 0.0509 
  3.75 (m) 1.26 0.140 1.24 0.120 
8 Glutamine 2.15 (m) 0.250 0.0268 0.285 0.0369 
  2.44 (m) 0.141 0.107 0.231 0.0830 
  3.77 (m) 1.04 0.211 0.909 0.192 
9 Pyruvate 2.41 (s)* 0.120 0.0157 0.152 0.0313 
10 Citrate 2.65 (d) 0.123 0.0546 0.116 0.0279 
11 Aspartic Acid 2.82 (m) 0.134 0.0780 0.183 0.0643 
12 Creatine 3.03 (s) 0.409 0.0440 0.361 0.0568 
  3.92 (s) 0.358 0.181 0.488 0.0706 
13 Choline 3.51 (t) 0.698 0.129 0.830 0.127 
14 Phosphorylcholine 3.61 (t) 0.929 0.336 0.633 0.353 
15 Glycine 3.55 (s) 0.767 0.0960 0.751 0.0178 
16 Glycerol 3.56 (m) 1.28 0.0550 1.22 0.0954 
  3.64 (m) 1.01 0.194 0.831 0.135 
  3.91 (m) 0.898 0.157 0.910 0.0871 
17 
Phenylacetyl-
3.68 (m) 0.771 0.220 0.650 0.190 








3.82 (s) 0.380 0.186 0.403 0.129 
19 Glucose 3.51 (m) 0.698 0.129 0.839 0.127 
  3.66 (m) 0.866 0.226 0.671 0.162 
  3.83 (m) 1.20 0.136 1.19 0.129 
a
The relative intensity of metabolites is expressed with their normalized peak height. 
Values are represented as mean ± SD (standard deviation). The statistics are as 
follows: significance difference between the control group (n=8) and treated group (n=6) 
is based on two tailed student t test (* p<0.05, ** p<0.01, ***p<0.001). 
 
 






H chemical shift and multiplicity assignment of the metabolites identified 





 1H (ppm) 
and 
Multiplicity 
Normalized Peak Intensity %
 a
 
Control (n=8)  Treated (n=6)  
Mean  SD Mean  SD 
1 Leucine 0.94 (m) 0.284 0.0777 0.314 0.175 
2 Valine 1.04 (d) 0.199 0.224 0.333 0.167 
3 Isoleucine 0.99 (t) 0.796 0.0429 0.768 0.0683 
  1.02 (d) 0.571 0.223 0.451 0.0323 
4 Lactate 1.33 (d) 5.06 2.26 3.64 0.730 
5 Lipids 2.00 (m) 0.287 0.0967 0.374 0.0806 
6 Glutamate 2.09 (m) 2.45 0.158 2.57 0.261 
  3.75 (m) 1.74 0.351 2.10 0.578 
7 Pyruvate 2.41 (s) 0.205 0.105 0.238 0.156 
8 Taurine 3.26 (t) 0.989 0.452 1.53 0.755 
  3.40 (t) 0.227 0.211 0.336 0.337 
9 Phosphorylcholine 3.61 (t) 0.667 0.849 0.334 0.187 




3.82 (s) 1.06 0.229 1.20 0.0829 
12 Glucose 3.51 (m) 1.66 0.390 1.79 0.640 
  3.66 (m) 0.310 0.0970 0.360 0.170 
  3.83 (m) 1.16 0.450 0.910 0.280 
a
The relative intensity of metabolites is expressed with their normalized peak height. 
Values are represented as mean ± SD (standard deviation). The statistics are as 
follows: significance difference between the control group (n=8) and treated group 
(n=6) is based on two tailed student t test (* p<0.05, ** p<0.01, ***p<0.001). 






H chemical shift and multiplicity assignment of the metabolites identified 
in aqueous fraction of heart samples for both control and treated group as measured 
by 
1
H NMR spectroscopy. 
Key Metabolites 
 1H (ppm) 
and 
Multiplicity 
Normalized Peak Intensity %
 a
 
Control (n=8)  Treated (n=6)  
Mean  SD Mean  SD 
1 Leucine 0.94 (d) 0.165 0.0575 0.141 0.0669 
2 Valine 1.04 (d) 0.233 0.0889 0.210 0.0926 
3 Isoleucine 0.99 (t) 0.286 0.110 0.257 0.111 
  1.02 (d) 0.173 0.0665 0.154 0.0696 
4 Lactate 1.33 (d) 5.02 1.69 4.72 2.26 
5 Acetate 1.91 (s) 0.0661 0.0248 0.0588 0.0302 
6 Lipids 2.00 (m) 0.0886 0.0338 0.0803 0.0385 
7 Glutamate 2.09 (m) 0.151 0.0487 0.136 0.0575 
  3.75 (m) 0.414 0.228 0.496 0.256 
8 Glutamine 2.15 (m) 0.431 0.142 0.357 0.159 
  2.44 (m) 0.224 0.0726 0.189 0.0908 
  3.77 (m) 0.394 0.172 0.408 0.193 
9 Pyruvate 2.41 (s) 0.116 0.0453 0.109 0.0534 
10 Citrate 2.65 (d) 0.0851 0.0313 0.0673 0.0344 
11 Tryptamine 3.18 (t) 0.0438 0.0211 0.0397 0.0272 
12 Aspartic Acid 3.89 (m) 0.320 0.188 0.380 0.203 
13 Choline 3.51 (t) 0.332 0.150 0.381 0.143 
14 Phosphorylcholine 3.61 (t) 0.251 0.125 0.232 0.113 
15 Glycine 3.55 (s) 0.162 0.119 0.318 0.180 
16 Glycerol 3.56 (m) 0.357 0.147 0.474 0.235 
  3.64 (m) 0.286 0.100 0.300 0.141 
  3.91 (m) 0.341 0.182 0.359 0.186 
17 Phenylacetyl-
glycine (PAG) 
3.68 (m) 0.206 0.0814 0.199 0.0924 




3.82 (s) 0.0712 0.0284 0.0625 0.0290 




19 Glucose 3.51 (m) 0.332 0.150 0.381 0.143 
  3.66 (m) 0.248 0.0933 0.265 0.130 
  3.83 (m) 0.409 0.222 0.487 0.254 
a
The relative intensity of metabolites is expressed with their normalized peak height. 
Values are represented as mean ± SD (standard deviation). The statistics are as 
follows: significance difference between the control group (n=8) and treated group 












H chemical shift and multiplicity assignment of the metabolites identified 
in aqueous fraction of kidney samples for both control and treated group as measured 
by 
1
H NMR spectroscopy. 
Key Metabolites 
 1H (ppm) 
and 
Multiplicity 
Normalized Peak Intensity %
 a
 
Control (n=8)  Treated (n=6) 
Mean  SD Mean  SD 
1 Leucine 0.94 (d)* 0.612 0.110 0.473 0.0972 
2 Valine 1.04 (d)** 1.13 0.194 0.825 0.161 
3 Isoleucine 0.99 (t)** 1.35 0.232 0.984 0.172 
  1.02 (d)** 0.835 0.165 0.594 0.109 
4 Lactate 1.33 (d) 1.37 0.166 1.58 0.277 
5 Acetate 1.91 (s)** 0.291 0.0347 0.223 0.0279 
6 Lipids 2.00 (m)* 0.340 0.0513 0.277 0.0433 
7 Glutamate 2.08 (m) 0.442 0.0649 0.406 0.0574 
  3.75 (m) 0.493 0.0785 0.614 0.146 
8 Glutamine 2.15 (m) 0.359 0.0633 0.293 0.0520 
  2.44 (m) 0.198 0.0689 0.221 0.0317 
  3.77 (m) 0.617 0.0980 0.619 0.0863 
9 Pyruvate 2.41 (s) 0.415 0.0636 0.399 0.0544 
10 Citrate 2.65 (d)** 0.325 0.0561 0.234 0.0514 
11 Aspartic Acid 3.89 (m)* 0.312 0.0690 0.439 0.126 
12 Creatine 3.03 (s)* 0.892 0.144 0.584 0.126 
  3.92 (s)* 0.372 0.0689 0.485 0.110 
13 Creatinine 3.05 (s) 0.552 0.0812 0.478 0.0678 
14 Choline 3.20(s)* 0.138 0.0418 0.0932 0.0315 
  3.51 (t) 0.228 0.105 0.340 0.200 
15 Phosphorylcholine 3.61 (t) 0.468 0.0523 0.452 0.0734 
16 Glycine 3.55 (s) 0.377 0.0341 0.430 0.222 
17 Glycerol 3.56 (m)*** 0.332 0.147 0.477 0.249 
  3.64 (m) 0.434 0.0425 0.554 0.0360 
  3.91 (m) 0.531 0.0848 0.587 0.0881 







3.68 (m) 0.354 0.0380 0.353 0.0438 




3.82 (s) 0.231 0.0200 0.232 0.0309 
20 Glucose 3.51 (m)** 0.228 0.105 0.340 0.200 
  3.66 (m)** 0.347 0.0359 0.455 0.0366 
  3.83 (m)* 0.390 0.0759 0.549 0.145 
a
The relative intensity of metabolites is expressed with their normalized peak height. 
Values are represented as mean ± SD (standard deviation). The statistics are as 
follows: significance difference between the control group (n=8) and treated group 

























H chemical shift assignment of the metabolites identified in lipid fraction of liver samples for both control and treated group as 
measured by 
1
H NMR spectroscopy. 
 
Key Lipids components assigned δ/ppm
 b
 
Normalized Peak Intensity 
a
 
Control (n=8) Treated (n=6) 
Mean± SD Mean± SD 
1 Cholesterol 18-CH3  0.675
∆
 1.590±0.257 1.51±0.278 
2 Cholesterol ester 15-CH2,19-CH3  0.831* 0.910±0.350 1.27±0.352 
 Cholesterol 15-CH2  0.836* 0.950±0.377 1.32±0.378 
 Fatty acid chain (methylenes) x-CH2-(CH2)n-CH2-y  0.843* 0.953±0.357 1.32±0.354 
3 Fatty acid chain (methylenes) x-CH2-(CH2)n-CH2-y  1.045* 0.252±0.00537 0.285±0.00506 
    1.057* 0.265±0.00589 0.301±0.00559 
4 Fatty acid chain (methylenes) x-CH2-(CH2)n-CH2-y  1.183* 0.255±0.00703 0.295±0.00708 
 Cholesterol 16-CH2,20-CH,23-CH2  1.192* 0.259±0.00875 0.306±0.00897 
 Cholesterol ester 16-CH2,20-CH,22-CH2,23-CH2     —    
5 Fatty acid chain (methylenes) x-CH2-(CH2)n-CH2-y  1.371** 0.978±0.105 1.18±0.103 
 Cholesterol 2-CH2,4-CH2,11-CH2     —   
 Cholesterol ester 11-CH2     —     
6 Fatty acid chain (ß-methylenes) x-CH2-CH2-CH2-CO-y  1.422* 0.254±0.0157 0.321±0.0168 




 Cholesterol 7-CH2,15-CH2,25-CH  1.481* 0.309±0.00336 0.332±0.00247 
 Cholesterol ester 2-CH2,4-CH2,7-CH2,15-CH2,25-CH     —     
7 Cholesterol 2-CH2  1.592
∆
 0.652±0.0197 0.664±0.0150 
    1.613
∆
 0.746±0.0393 0.717±0.0315 
8 










 Cholesterol ester 1-CH2     —   
9 Cholesterol 4-CH2  2.041
∆
 0.859±0.117 0.780±0.132 
    2.055
∆
 0.818±0.107 0.745±0.119 
    2.068
∆
 0.347±0.0154 0.312±0.0156 
    2.091
∆
 0.115±0.00140 0.105±0.00154 
    2.108
∆
 0.0933±0.00116 0.0891±0.00126 
a
The relative intensity of metabolites is expressed with their normalized peak height. Values are represented as mean ± SD 
(standard deviation). The statistics are as follows: significance difference between the control group (n=8) and treated group (n=6) 
is based on two tailed student t test (
∆
 p≥0.05, * p<0.05, ** p<0.01, ***p<0.001).
 b
Each δ and the normalized peak intensity 










H chemical shift assignment of the metabolites identified in lipid fraction of heart samples for both control and treated group as 
measured by 
1
H NMR spectroscopy. 
 
Key Lipids components assigned δ/ppm
 b
 
Normalized Peak Intensity 
a
 
Control (n=8) Treated (n=6) 
Mean± SD Mean± SD 
1 Cholesterol 18-CH3  0.677
∆
 0.296±0.0120 0.314±0.0162 
2 Cholesterol ester 15-CH2,19-CH3  0.831** 2.93±0.569 2.50±0.623 
 Cholesterol 15-CH2  0.836*** 3.03±0.606 2.55±0.705 
 Fatty acid chain (methylenes) x-CH2-(CH2)n-CH2-y  0.842*** 2.96±0.553 2.49±0.655 
3 Fatty acid chain (methylenes) x-CH2-(CH2)n-CH2-y  0.941* 0.252±0.00390 0.230±0.00150 
 Cholesterol 1-CH2,14-CH,17-CH,22-CH2,23-CH2,24-CH2  1.020** 0.490±0.0136 0.432±0.0106 
 Cholesterol ester 1-CH2,14-CH,17-CH,23-CH2,24-CH2     —      
4 Fatty acid chain (methylenes) x-CH2-(CH2)n-CH2-y  1.039** 0.524±0.0156 0.462±0.0129 
    1.054** 0.511±0.0146 0.453±0.0113 
    1.071* 0.489±0.0130 0.439±0.00850 
5 Fatty acid chain (methylenes) x-CH2-(CH2)n-CH2-y  1.187* 0.549±0.0173 0.495±0.0112 
 Cholesterol 16-CH2,20-CH,23-CH2     —   
 Cholesterol ester 16-CH2,20-CH,22-CH2,23-CH2     —   




6 Fatty acid chain (methylenes) x-CH2-(CH2)n-CH2-y  1.285** 4.10±1.02 3.59±0.963 
 Cholesterol 2-CH2,4-CH2,11-CH2  1.371*** 1.99±0.262 1.66±0.288 
 Cholesterol ester 11-CH2     —      
7 Fatty acid chain (ß-methylenes) x-CH2-CH2-CH2-CO-y  1.422** 0.650±0.0254 0.554±0.0306 
 Cholesterol 7-CH2,15-CH2,25-CH  1.469* 0.427±0.00970 0.390±0.00560 
 Cholesterol ester 2-CH2,4-CH2,7-CH2,15-CH2,25-CH  1.481* 0.442±0.0114 0.403±0.00620 
8 Cholesterol 2-CH2  1.577
∆
 0.846±0.193 0.736±0.0367 
    1.599
∆
 0.775±0.275 0.683±0.0517 
    1.615
∆
 0.757±0.260 0.697±0.0753 
    1.629
∆
 0.789±0.154 0.753±0.0706 
9 Cholesterol 4-CH2  2.042
∆
 0.33±0.0300 0.339±0.0339 
    2.071
∆
 0.225±0.00710 0.234±0.00870 
    2.095
∆
 0.168±0.00260 0.178±0.00330 
    2.109
∆
 0.159±0.00230 0.167±0.00290 
a
The relative intensity of metabolites is expressed with their normalized peak height. Values are represented as mean ± SD 
(standard deviation). The statistics are as follows: significance difference between the control group (n=8) and treated group (n=6) 
is based on two tailed student t test (
∆
 p≥0.05, * p<0.05, ** p<0.01, ***p<0.001).
 b
Each δ and the normalized peak intensity 
represents all the protons assigned in each Key group. 
 
 






H chemical shift assignment of the metabolites identified in lipid fraction of kidney samples for both control and treated group as 
measured by 
1
H NMR spectroscopy. 
 
Key Lipids components assigned δ/ppm 
b
 
Normalized Peak Intensity 
a
 
Control (n=8) Treated (n=6) 
Mean± SD Mean± SD 
1 Cholesterol 18-CH3  0.678
∆
 0.605±0.161 0.562±0.219 
2 Cholesterol 2-CH2  1.577
∆
 0.789±0.130 0.816±0.234 
    1.599
∆
 0.651±0.137 0.679±0.273 
    1.614
∆
 0.654±0.213 0.697±0.355 
    1.629
∆
 0.741±0.301 0.771±0.396 
     1.644∆ 0.748±0.402 0.722±0.389 
3 Cholesterol 4-CH2  2.045
∆
 0.307±0.0929 0.295±0.106 
    2.059
∆
 0.298±0.0892 0.285±0.0958 
    2.071
∆
 0.198±0.0548 0.184±0.0458 
    2.094
∆
 0.187±0.0446 0.168±0.0495 
    2.108
∆
 0.175±0.0395 0.157±0.0457 
     2.123∆ 0.129±0.0245 0.119±0.0202 
4 Glycolipid sugars -CH, -CH2  3.525* 0.117±0.0243 0.108±0.00851 




5 Glycolipid sugars -CH, -CH2  3.914* 0.153±0.0277 0.141±0.00931 
 Glycerophosphatidylethanolamine x-CH2-CH2-NH2     —   
 Plasmalogen      —   
  Sphingomyelin x-CHOH-CHR-CH2-O-y     —     
6 Glycerophospholipids (phosphatidylcholine, 
phosphatidylethanolamine, phosphatidylserine, 
phosphatidylinositol) 
CH2OR1-CHOR2-CH2-x  3.979* 0.140±0.0267 0.129±0.00985 
  Sphingomyelin x-CHOH-CHR-CH2-O-y     —     
7 Glycerophospholipids (phosphatidylcholine, 
phosphatidylethanolamine, phosphatidylserine, 
phosphatidylinositol) 






 Triglycerides CH2OR1-CHOR2-CH2OR3     —   
a
The relative intensity of metabolites is expressed with their normalized peak height. Values are represented as mean ± SD 
(standard deviation). The statistics are as follows: significance difference between the control group (n=8) and treated group (n=6) 
is based on two tailed student t test (
∆
 p≥0.05, * p<0.05, ** p<0.01, ***p<0.001). 
b
Each δ and the normalized peak intensity 
represents all the protons assigned in each Key group. 
 




Appendix 2 Supporting information of Chapter 5 
Table S5.1 Metabolites peak intensities expressed with their peak heights normalized 
to total integral. Results are obtained from hypercholesterolemic rat urine samples 
collected on day 2 for both control and treated group.  
 











Normalized peak intensity % 
Control (n=8) Treated (n=8) 
Mean  SD Mean  SD 
1 3-D-Hydroxybutyrate 1.203 (d)** 0.219 0.0508 0.402 0.127 
2 Lactate 1.327 (d) 0.283 0.0696 0.438 0.148 
3 Acetate 1.923 (s)** 0.251 0.0515 0.350 0.0607 
4 Glutamate 2.347 (m)*** 0.285 0.0586 0.506 0.130 
5 Pyruvate 2.409 (s)*** 1.60 0.385 0.699 0.316 
6 Succinate 2.422 (s)*** 0 0 0.375 0.240 
7 Glutamine 2.445 (m)*** 2.89 0.564 0.728 0.280 
8 Citrate 2.722 (d) 3.04 1.54 2.06 0.275 
9 Hypotaurine 3.352 (t)** 0.176 0.0158 0.235 0.0448 
10 Trimethylamine 2.886 (s)*** 0.146 0.0464 0.378 0.154 
11 Creatine 3.047 (s)*** 5.48 0.718 15.5 6.15 
  3.930 (s)*** 0.279 0.0400 3.23 1.54 
12 Creatinine 4.057 (s)* 0.586 0.0721 0.819 0.218 
13 Dimethylglycine 2.931 (s) 0.741 0.163 0.933 0.400 
14 Phenylalanine 7.424 (m)** 0.136 0.0312 0.336 0.139 
  3.120 (m) 0.695 0.0563 0.581 0.209 
15 Choline 3.204 (s) 0.403 0.0523 0.457 0.196 
16 Phosphocholine 3.232 (s)*** 0.314 0.0308 0.650 0.211 
17 Trimethylamine N-
oxide 
3.269 (s) 6.23 0.904 5.42 1.94 
18 Taurine  3.427 (t)  0.590 0.127 1.41 1.62 
19 Glycine 3.567 (s) 0.453 0.189 0.521 0.338 
20 Lysine 3.765 (t) 0.595 0.242 1.01 0.517 
21 Tyrosine 7.191 (m) 0.231 0.0605 0.144 0.142 
  7.161 (m)** 0.153 0.0504 0.233 0.0525 
22 Hippurate 7.642 (t) 0.270 0.183 0.237 0.126 




  7.554 (t) 0.602 0.432 0.553 0.293 
  3.97 (d) 0.511 0.304 0.485 0.195 
23 Formate 8.464 (s) 0.129 0.274 0.0275 0.0224 
24 Alanine 1.478 (d)*** 0.185 0.0326 0.297 0.0560 
25 Phenylacetylglutamine 7.41 (m)** 0.169 0.0327 0.363 0.150 
26 Betaine 3.893 (s)* 0.415 0.0402 0.588 0.175 
27 Glucose 3.255 (m) 0.250 0.250 0.328 0.372 
  3.5 (m)*** 0.255 0.106 0.428 0.0485 
28 Tryptophan 7.176 (d) 0.216 0.0905 0.280 0.108 
  7.294 (d)* 0.164 0.0278 0.230 0.0657 
  7.538 (d) 0.281 0.171 0.262 0.117 
Values are represented as mean  SD (standard deviation). The statistics are as 
follows: Significant difference between control group (n=8) and treated group (n=8) is 
based on two tailed student’s t test (* p0.05, ** p0.01, *** p0.001). A lower p value 


































Table S5.2 Metabolites peak intensities expressed with their peak heights normalized 
to creatinine. Results are obtained from hypercholesterolemic rat urine samples 
collected on day 2 for both control and treated group.  
 











Normalized peak intensity % 
Control (n=8) Treated (n=8) 
Mean  SD Mean  SD 
1 3-D-Hydroxybutyrate 1.203 (d)* 37.8 9.76 49.5 11.0 
2 Lactate 1.327 (d) 48.8 13.2 55.1 17.3 
3 Acetate 1.923 (s) 43.0 7.70 44.3 8.26 
4 Glutamate 2.347 (m) 48.6 7.50 64.3 20.6 
5 Pyruvate 2.409 (s)*** 279 76.6 82.0 37.7 
6 Succinate 2.422 (s)** 0 0 49.0 36.6 
7 Glutamine 2.445 (m)*** 506 132 92.1 33.5 
8 Citrate 2.722 (d)* 528 280 266 68.9 
9 Hypotaurine 3.352 (t) 30.4 3.69 31.7 15.4 
10 Trimethylamine 2.886 (s)* 25.8 9.02 49.9 27.5 
11 Creatine 3.047 (s)* 936 52.1 2190 1440 
  3.930 (s)** 48.3 9.35 466 316 
12 Creatinine 4.057 (s) 100 0 100 0 
13 Dimethylglycine 2.931 (s) 128 34.2 128 71.6 
14 Phenylalanine 7.424 (m)* 23.1 3.82 47.2 30.3 
  3.120 (m)*** 119 7.98 71.7 21.0 
15 Choline 3.204 (s) 69.0 8.15 59.2 29.6 
16 Phosphocholine 3.232 (s) 54.6 6.41 90.7 60.8 
17 Trimethylamine N-
oxide 
3.269 (s)** 1080 203 682 247 
18 Taurine 3.427 (t) 100 19.0 238 366 
19 Glycine 3.567 (s) 77.6 31.8 59.7 37.6 
20 Lysine 3.765 (t) 100 41.8 138 78.8 
21 Tyrosine 7.191 (m)** 39.6 10.2 16.1 15.9 
  7.161 (m) 26.1 7.61 31.9 16.7 
22 Hippurate 7.642 (t) 47.2 33.2 27.2 10.2 
  7.554 (t) 105 78.1 63.6 22.2 
  3.970 (d) 89.2 56.2 57.7 12.7 




23 Formate 8.464 (s) 24.1 52.8 3.60 3.03 
24 Alanine 1.478 (d) 31.9 5.86 37.5 7.00 
25 Phenylacetylglutamine 7.410 (m) 29.0 4.84 50.9 32.6 
26 Betaine 3.893 (s) 71.6 10.2 77.9 36.4 
27 Glucose 3.255 (m) 41.8 41.4 37.0 43.7 
  3.500 (m) 43.6 19.4 55.9 18.3 
28 Tryptophan 7.176 (d) 36.8 14.5 40.1 28.3 
  7.294 (d) 28.2 4.98 30.7 14.3 
  7.538 (d) 49.0 31.2 30.8 8.28 
Values are represented as mean  SD (standard deviation). The statistics are as 
follows: Significant difference between control group (n=8) and treated group (n=8) is 
based on two tailed student’s t test (* p0.05, ** p0.01, *** p0.001). A lower p value 






































Table S5.3 Concentrations of selected bio-elements present in hypercholesterolemic 
rat blood serum samples collected on day of sacrifice for both control and treated 




Concentration / ng kg
-1
 
Control (n=8) Treated (n=6) 
Mean  SD Mean  SD 
Li* 0.0115 0.000756 0.00946 0.00180 
Be 0.000450 2.90E-05 0.000472 7.38E-05 
B** 0.116 0.00905 0.0980 0.0077 
Na*** 34800 452 37200 786 
Mg  358 40.3 396 36.5 
Al 0.159 0.0928 0.084 0.00722 
K*** 2060 178 2690 177 
Sc* 0.0120 0.000756 0.0110 0.000467 
V** 0.0367 0.00150 0.0441 0.00126 
Mn* 0.0371 0.0197 0.0192 0.00180 
Fe 70.1 3.13 77.2 9.20 
As 0.0232 0.00251 0.0256 0.00655 
Rb*** 0.179 0.0168 0.259 0.0349 
Sr 0.0335 0.00569 0.0347 0.00279 
Y* 0.000110 6.44E-05 3.42E-05 7.00E-06 
Nb 6.50E-05 2.39E-05 8.68E-05 3.20E-05 
Rh* 0.000170 0.000126 4.62E-05 1.01E-05 
In** 0.000120 1.28E-05 0.000141 1.21E-05 
Cs** 0.00176 8.66E-05 0.00195 0.000131 
Ba 0.00916 0.00191 0.00737 0.00217 
Gd 4.60E-05 1.30E-05 4.77E-05 2.80E-05 
Tb 7.00E-06 1.85E-06 7.08E-06 1.91E-06 
Dy 3.90E-05 1.86E-05 3.73E-05 8.13E-06 
Ho 6.80E-06 2.84E-06 5.88E-06 1.31E-06 
Tm 5.3E-06 1.08E-06 5.01E-06 1.47E-06 
Lu 6.70E-06 1.37E-06 6.14E-06 2.95E-06 
Hf 0.000160 2.17E-05 0.000149 1.76E-05 
Ta** 5.50E-05 1.05E-05 9.50E-05 2.46E-05 
Pt 0.000420 4.95E-05 0.000413 7.34E-05 
Au 0.127 0.0711 0.143 0.0330 
Bi* 0.000610 0.000265 0.000334 2.69E-05 
Th 6.6E-05 1.08E-05 5.71E-05 9.12E-06 
U 3.00E-05 1.06E-05 2.41E-05 4.83E-06 
Values are represented as mean  SD (standard deviation). The statistics are as 
follows: Significant difference between control group (n=8) and treated group (n=6) 
is based on two tailed student’s t test (* p0.05, ** p0.01, *** p0.001).  
